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Abstract 
 
Neutrophils adopt a highly polarized morphology and integrate many matrix-
specific signals to undergo specialized migratory events to pursue invading pathogens.  
While these matrix-specific signaling events have emerged as crucial elements for proper 
migration and recruitment of neutrophil cells, the underlying signaling networks remain 
poorly defined.  We have identified Pyk2, a FAK (focal adhesion kinase) family non-
receptor tyrosine kinase, as a beta2-integrin-dependent regulator of rear contraction in 
migrating neutrophil cells.  We show that Pyk2 is specifically activated by beta2-integrin 
and that Pyk2 mediates contraction by interaction with p190RhoGEF and RhoA thereby 
regulating the myosin contractility at the rear of the cell.  These data elucidate a novel 
mechanism in which Pyk2 integrates matrix-specific substrate interaction with the 
signaling network responsible for the polarized morphology needed for neutrophil 
migration. 
Another crucial component of neutrophil migration that is not fully understood is 
the mechanism that governs actin cytoskeleton dynamics and assembly in neutrophils.  
The asymmetric accumulation of filamentous actin (F-actin) at the leading edge provides 
the driving force for protrusion and is essential for the development and maintenance of 
neutrophil polarity.  By using neutrophil-like HL-60 cells, we describe a pivotal role for 
Rictor, a component of Mammalian Target of Rapamycin Complex 2 (mTORC2), in 
regulating assembly of the actin cytoskeleton during neutrophil chemotaxis.  Depletion of 
Mammalian Target of Rapamycin (mTOR) and Rictor, but not Raptor, impairs actin 
polymerization, leading edge establishment and directional migration in neutrophils 
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stimulated with chemoattractants.  Intriguingly, depletion of mSin1, an integral 
component of mTORC2, causes no detectable defects in neutrophil polarity and 
chemotaxis.  In addition, experiments with chemical inhibition and kinase-dead mutants 
indicate that mTOR kinase activity and AKT phosphorylation are dispensable for 
chemotaxis.  Instead, our results suggest that the small Rho GTPases Rac and Cdc42 
serve as the downstream effectors of Rictor to regulate actin assembly and organization 
in neutrophils.  Together, our findings reveal an mTORC2- and mTOR kinase -
independent function and mechanism of Rictor in the regulation of neutrophil 
chemotaxis. 
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Chapter # 1: Introduction 
 
1.1.  Cell Migration 
Most eukaryotic cells are capable of migrating, and given the appropriate 
migratory and micro-environmental signals, most cells do migrate (Weiner 2002, Friedl 
2004).  Cell migration is necessary in many biological and pathological processes, 
including embryogenesis, the inflammatory response, tissue repair, regeneration, cancer, 
arthritis, atherosclerosis, osteoporosis, and congenital brain defects (Webb et al. 2002). 
Cell migration is a universal, multi-step progression that can be conceptually 
thought of as a repeating cycle (Friedl 2004, Webb et al. 2003, Figure 1.1).  First, a 
protrusion must extend from the cell.  Protruding membranes are driven by 
polymerization of the actin cytoskeleton (Webb et al. 2003).  Second, the protrusion at 
the front of the cell must form stable attachments to the substrate.  Stable interactions are 
generally mediated by the integrin family of transmembrane receptors (Webb et al. 
2003).  Next, the cell body has to translocate forward, and finally, the adhesion at the rear 
of the cell must be detached, and the rear of the cell must retract (Webb et al. 2003).  This 
is accomplished by the contractility of the actin-myosin machinery (Ridley et al. 2003).  
While this process is universal amongst migrating cells, there are many differences with 
respect to cell type and microenvironment (Friedl 2004). 
 
Adhesion in migration 
One of the crucial steps in the migratory cycle, is the necessity of the cell’s 
protrusion to form stable attachments with the substrate upon which it is crawling (Webb 
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et al. 2003).  In many migrating cells, this attachment is mediated by the integrin family 
of transmembrane receptors (Webb et al. 2003).  Integrins are heterodimeric proteins 
consisting of an alpha chain and a beta chain (Berton et al. 1999).  There are 
approximately 17 different alpha chains and eight different beta chains (Berton et al. 
1999).  The particular alpha and beta pairing determines the type of ECM molecule or 
counter cellular receptor to which the integrin will bind (Berton et al. 1999).  Integrins 
mediate the linkage between the ECM or counter cellular receptor substrate to the actin 
cytoskeleton of the cell by interacting with actin-associated molecules or adaptor proteins 
(Berton et al. 1999).  Integrins are clearly important for the structural integrity of cell 
adhesions, but they are also important signaling receptors, known to receive signals 
(“inside out signaling”) and transduce signals (“outside in signaling”) which regulate the 
rearrangement of the actin cytoskeleton and cellular movement (Berton et al. 1999).  
Integrins are undoubtedly crucial elements of the basic migratory machinery, as well as 
important in mediating the regulatory processes involved in migration. 
 
Mesenchymal and amoeboid migration 
Cell migration can be divided into two general types: mesenchymal and amoeboid 
migration (Friedl 2004).  Mesenchymal cells (e.g. fibroblasts, myoblasts, single 
endothelial cells, and sarcoma cells) are relatively slow moving cells, migrating at a 
velocity of 0.1-2 μm/min (Friedl 2004).  These cells adopt a spindle-shape morphology 
(Grinnell 1994, Tamariz et al. 2002), which is dependent upon integrin-mediated 
adhesions and the presence of high traction forces on both cell poles (Ballestrem et al. 
2001, Tamariz et al.2002).  The integrin-mediated adhesions in mesenchymal cells are 
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large, heterogeneous complexes, termed focal adhesions (Parsons et al. 2000).  These 
structures link the ECM to the actin cytoskeleton by way of actin stress fibers, and consist 
of many signaling molecules as well as structural proteins (Parsons et al. 2000).  Focal 
adhesions are dynamic, and based on their composition and organization, regulate the 
migration of these cells (Parsons et al. 2000). 
Amoeboid cells (e.g. neutrophils, lymphocytes, macrophages, hematopoietic stem 
cells, and certain tumor cells), on the other hand, are relatively fast moving cells.  They 
migrate at a velocity of 10-30μm/min (Friedl 2004).  Amoeboid cells exhibit a highly 
polarized morphology, utilizing actin assembly and short-lived interactions with the 
substrate to facilitate their speedy migration (Weiner 2002).  This is in contrast to the 
stable focal adhesions observed in mesenchymal cells.  This lack of stable focal contacts 
is thought to allow these cells to turn over membrane rapidly and move at such a high 
velocity (Friedl 2004).  These mechanistic differences indicate that amoeboid cells may 
exploit a distinct molecular program to regulate cell-ECM adhesion during migration. 
 
1.2.  Neutrophil Chemotaxis 
Chemotaxis, the ability of cells to migrate up a gradient of chemoattractant is 
essential for many biological responses, including the ability of single celled organisms 
to hunt and mate, the ability of the axon projections in the developing nervous system to 
find their mark, and for cells of the innate immune system, such as neutrophils, to locate 
and kill invading pathogens (Weiner 2002).  The ability of neutrophils to move to and 
destroy microbes is an indispensable and powerful component of our immune system, as 
demonstrated by several human disorders in which a direct deficiency, or the converse, a 
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direct over activation of neutrophils occur (Nathan 2006).  A few such syndromes include 
the two potentially fatal disorders; Leukocyte Adhesion Deficiency and Chronic 
Granulomatous Disease, as well as chronic inflammatory diseases, such as rheumatoid 
arthritis (Nathan 2006).   
Neutrophils constitute the majority of our white blood cells, and can mobilize 
rapidly in order to function as key players in inflammation (Nathan 2006).  These cells 
can kill microbes by one of two ways; by either releasing anti-bacterial molecules from 
their granules or by phagocytosis, a process by which the neutrophils ingest and kill the 
microbe (Nathan 2006).  However, before the neutrophil can clear the site of invading 
pathogens, it must exit the blood stream and travel to the site of infection (Nathan 2006).  
Neutrophils do so in what was described originally as a three-step adhesion cascade, but 
has now been expanded upon to include the following events: capture, slow rolling, firm 
arrest, intraluminal crawling on the inside of the endothelial wall of the blood vessel, 
diapedesis – paracellular migration out of the blood vessel, and chemotactic migration 
through the basement membrane and to the site of infection (Ley et al. 2007, Figure 1.3).  
Neutrophil chemotaxis, being a key prerequisite to neutrophil function, is an area of 
intense interest, and we are now beginning to elucidate the complicated signaling 
mechanisms that govern this process. 
 
Neutrophil compass 
Neutrophils interpret chemoattractant gradients and move in the direction of 
increasing concentration.  Neutrophils polarize their cell body in order to enable this 
directional movement.  These cells assign their leading edge (pseudopod) toward the 
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source of chemoattractant, and position their trailing edge (uropod) away from the 
chemoattractant source (Servant et al. 2000).  This morphological polarity is a result of 
an underlying molecular polarity.  Actin polymerization is localized to the leading edge 
enabling membrane protrusion, while activated myosin II is localized at the trailing edge, 
facilitating contraction at the rear of the cell (Xu et al. 2003).   
In order for a neutrophil cell to align its cell body with the chemical gradient, the 
neutrophil cell first utilizes receptors to receive a gradient of chemoattractants and then 
transmit them to intracellular information (Weiner 2002).  Next, the cells use this 
intracellular information to establish an internal gradient (Weiner 2002).  This 
interpretation is often referred to as the cell’s compass (Weiner 2002).  Lastly, a cell will 
then use the internal gradient to activate effector molecules to generate cellular polarity 
(Weiner 2002). 
The components of the cellular compass do not appear to include the 
chemoattractant receptors as these receptors usually remain uniformly distributed 
(Servant et al. 1999).  Chemoattractants bind to G protein coupled receptors (GPCRs) 
(Gerard et al. 1994).  The Gβγ subunit is then released from the Gαi subunit.  The Gαi 
subunit does not appear to be important for the cells chemotactic behavior (Neptune et. al 
1999).  The Gβγ subunit, however, is crucial for neutrophil chemotaxis (Rickert et al. 
2000, Suire et al. 2006, Weiner 2002).  Importantly, the localization of the GPCR does 
remain uniform which is important for the cell to be able to continuously assess potential 
changes in the gradient (Servant et al. 1999). 
While the distribution of the chemoattractant receptors remains uniform, several 
important signaling molecules exhibit strong gradients that are aligned with the gradient 
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of the chemoattractant.  Phosphatidylinositol 3,4,5-trisphosphate (PI[3,4,5]P3) and active 
(GTP-bound) Rac (one of the Rho GTPases) strongly localize to the leading edge of 
chemoattractant-stimulated cells.  The asymmetric distribution of PI(3,4,5)P3 can be 
attributed to the asymmetric distribution of PI3Kγ (Gomez-Mouton et al. 2004).  
PI(3,4,5)P3 appears to be a crucial component of the neutrophils compass.  Inhibiting 
PI3K with wortmannin and LY294002 prevents formation of the leading edge of the cell 
(Wang et al. 2003, Knall et al. 1997).  Also, experiments with isoform-specific inhibitors 
reveal PI3Kγ to be the crucial isoform in producing a leading edge in neutrophil cells 
(Ferguson et al. 2007, Van Keymeulen et al. 2006). 
Likewise, PI(3,4,5)P3-degrading enzymes have been proven necessary for proper 
polarization in neutrophil cells.  It has been reported that PI 3-phosphatase (PTEN) is 
necessary for directionality in mouse neutrophils (Hannigan et al. 2002).  However, 
conflicting reports conclude that PTEN is dispensable for motility and chemotaxis of 
mouse neutrophils (Nishio et.al. 2007).  However, PI 5-phosphatase SH2 domain 
containing inositol 5-phosphatase 1 (SHIP1) has emerged to be rather important for 
proper polarization and chemotaxis.  ship1 -/- neutrophil cells fail to polarize properly 
and acquire multiple membrane extensions (Nishio et al. 2007).  They also exhibit a 
marked decrease in migration speed (Nishio et al. 2007). 
 PI(3,4,5)P3 appears to be a crucial part of the cell’s compass; however, it is not 
the only component that contributes to the cell’s sense of direction.  Cells can still move 
up concentration gradients when PI(3,4,5)P3 is depleted or is in excess (Nishio et al. 
2007, Sasaki et al. 2000, Hirsch et al. 2000, Li et al. 2000, Franca et al. 2007, Hoeller et 
al. 2007, Andrew et al. 2007).  Furthermore, inhibiting PI3Kγ in Dictyostelium 
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discoideum, a soil-living amoeba that utilizes similar chemotactic molecular mechanisms, 
does not preclude the cell’s ability to form internal gradients of PI3K, PTEN, and Ras 
(Funamota et.al. 2002, Iijima et al. 2002, Sasaki et al. 2004).  Therefore, there appears to 
be a parallel pathway contributing to the cell’s compass.  Simultaneous deletion of 
patatin-like phospholipase A2 (PLA(2)) and two PI3K isoforms cause severe chemotactic 
defects in D. discoideum, indicating a potential parallel pathway (Chen et al. 2007). 
 Also, in D. discoideum, Tor complex 2 (TorC2) was shown to regulate PKBs in a 
PI(2,3,4)P3-independent manner (Kamimura et al. 2008).  Upon stimulation with a 
chemoattractant, two PKB homologs, PKBA and PKBR1, mediate phosphorylation of set 
of proteins, regardless of PI3K activity (Kamimura et al. 2008).  However, cells deficient 
in TorC2 show a decrease in phosphorylation of these proteins as well as impairment in 
chemotaxis (Kamimura et al. 2008).  These findings point to additional parallel pathways 
that are involved in the cell’s compass. 
 
Neutrophil polarity  
After the cell has interpreted the external gradient of chemoattractant to form an 
internal gradient of signaling molecules, it will then use this internal gradient to activate 
effector molecules to generate cellular polarity (Weiner 2002).  In order to generate and 
maintain morphological and molecular polarity, neutrophil cells utilize a network of 
distinct and divergent signaling pathways (Xu et al. 2003, Figure 1.2).  These pathways 
can be divided into what is termed as the “frontness pathway” and the “backness 
pathway” (Xu et al. 2003). 
8 
 
The frontness pathway is mediated by the trimeric G protein, Gi (Xu et al. 2003).  
Activated Gi produces 3’-phosphoinositol lipids (PI3Ps), which it turn activates Rac, a 
small RhoGTPase (Xu et al. 2003, Srinivasan et al. 2003).  Once activated, Rac promotes 
actin polymerization at the leading edge (Srinivasan et al. 2003).  Polymerizing actin acts 
in a positive feedback loop with PI3Ps and Rac to help organize the leading edge of cells 
(Srinivasan et al. 2003).  This pathway was elucidated through use of inhibitors and 
dominant negative proteins.  Stimulated cells treated with wortmannin, a PI3K inhibitor, 
or transfected with Rac N17, a dominant negative Rac mutant, produce a specific 
phenotype in which the cell remains rounded and is not able to polarize and form a 
pseudopod due to the fact that the cell is not able to polymerize actin (Xu et al. 2003).     
DOCK2, a PI(3,4,5)P3-dependent guanine exchange factor (GEF), has recently 
emerged as a GEF involved in activating Rac in chemotaxing neutrophils.  DOCK2 
associates with PI(3,4,5)P3 and translocates to the leading edge of the cell in a PI3K-
dependent manner.  Furthermore, DOCK-deficient mouse neutrophils exhibit severe 
polarization defects (Kunisaki et al. 2006).  These cells also exhibit a marked decrease in 
Rac1 and Rac2 activation as well as a decrease in actin polymerization and PI(3,4,5)P3 
accumulation at the leading edge of the cell (Kunisaki et al. 2006). 
The backness pathway, on the other hand, is mediated by G12/13 (Xu et al. 2003).  
G12/13 activates Rho, a small RhoGTPase, which activates ROCK, a Rho-dependent 
kinase, which finally activates myosin contractility at the trailing edge of the cells (Xu et 
al. 2003).  This pathway was also elucidated through use of inhibitors and dominant 
negative proteins.  Cells transfected with RhoA T19A, a RhoA dominant negative 
mutant, cells treated with Y-27632, a ROCK-specific inhibitor, and cells treated with 
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Blebbestatin, a myosin II-specific inhibitor, all elicit the same migration impairments.  
These cells form multiple leading edges, lateral projections, and long stretched trailing 
edges.  These morphological impairments are thought to be caused by the cells’ inability 
to contract myosin (Xu et al. 2003).       
More recently it was demonstrated that G12/13 likely activates Rho via 
PDZRhoGEF, a Rho-specific GEF.  In migration assays on fibronectin, PDZ-RhoGEF 
knockdown in dHL-60 cells causes apparent rear contraction defects in cellular 
morphology (Wong et al. 2007).  Also, PDZ-RhoGEF knockdown cells exhibit 
mislocalized phospho-myosin, as well as a marked reduction in activated RhoA (Wong et 
al. 2007).   
What allows the cells to carry out the frontness pathway exclusively in the front 
of the cell, while performing the backness pathway only at the back of the cell is the fact 
that the two pathways inhibit each other (Xu et al. 2003).  Mutual opposition between 
these assemblies induces them to separate from each other in the membrane (Xu et al. 
2003).  This also provides a mechanistic explanation for the ability of cells to polarize in 
uniform concentrations of chemoattractant and to perform U-turns rather than simply 
reversing polarity in response to changes in the direction of the attractant gradient; the 
cell follows the sensitive leading edge because positive feedback loops at the front and 
Rho/myosin-mediated contraction (inhibition) at the back render the leading edge much 
more sensitive to PI3P- and Rac-activating actions (Xu et al. 2003). 
It has been theorized that actin-myosin assemblies at the back of the cell inhibit 
frontness signals via lipid rafts.  It is thought that these lipid rafts may exclude signaling 
molecules such as PI3K and PI(3,4,5)P3 (Gomez-Mouton et al. 2001, Gomez-Mouton et 
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al. 2004, Seveau et al. 2001).  Another theory is that these signals are regulated by the 
cytoskeleton when it applies stretching force on localized areas of the membrane.  
Stretching a fibroblast will inhibit Rac1 at the plasma membrane in parallel to the axis of 
stretch (Katsumi et al. 2002).  These are two possibilities as to how the backness signals 
inhibit the frontness signals.  The frontness signals, on the other hand, suppress backness 
signals via Rac1 (Pestonjamasp et al. 2006).  Furthermore, this suppression may occur by 
way of hematopoietic protein 1 (Hem1), a scaffolding protein that contains a diverse set 
of potential polarity-regulating proteins.  Deletion of Hem1 prevents exclusion of 
activated myosin at the front of the cell while at the same time impairing the frontess 
signals (Weiner et al. 2006). 
These distinct and divergent signaling pathways cannot completely explain 
persistent chemotaxis.   Stimulation of neutrophils with fMLP in suspension causes 
transient membrane extensions, with polymerized actin recruited to the leading edge, but 
the actin-dependent polarity and frontness signals do not persist and decline 2–3 minutes 
after stimulation (Xu et al. 2003).  This is in contrast to cells stimulated on ECM 
substrates, including intracellular adhesion molecule 1 (ICAM-1), fibrinogen, fibronectin, 
or vitronectin; these cells become highly polarized and migratory, even 10 minutes after 
stimulation with fMLP (Xu et al. 2003, Schymeinsky et al. 2006, Eddy et al. 2000).  
These results highlight the critical role of matrix-specific interactions in regulating 
persistent polarity and motility in neutrophils. 
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Neutrophil-matrix interactions 
The above results point to cell-ECM interactions as an important regulatory 
process in chemotaxis.  Leukocyte Adhesion Deficiency Disease (LAD) is a potentially 
deadly disease involving neutrophils (Nathan 2006).  LAD type I is a hereditary disease 
involving mutations in the beta2-integrin subunit in which the expression of beta2 is lost 
(Berton et al. 1999).  LAD patients suffer from recurrent infections and delayed wound 
healing (Nathan 2006).  This is recapitulated in a mouse model in which beta2-integrin 
knock-out mice and ICAM-1, a beta2 interacting receptor expressed on endothelial cells, 
knock-out mice have impaired neutrophil recruitment into sites of infection (Berton et al. 
1999). 
This clinical impairment highlights the importance of the beta2-integrin subunit, 
and more generally speaking, cell-matrix signaling in neutrophil chemotaxis.  As 
mentioned previously, the neutrophil’s bactericidal utility is only functional if the 
neutrophil is able to leave the bloodstream and chemotax to the site of infection (Nathan 
2006).  These events are mediated in a specific adhesion cascade (Figure 1.3); the first 
events being capture of the neutrophil to the endothelial wall of the blood vessel, 
followed by rolling, and slow rolling (Ley et al. 2007).  These initial events are mediated 
by selectins, a family of cell adhesion glycoproteins (Ley et al. 2007).  The next 
important event is firm arrest which is ensued by beta1,2,7-integrin subunits (Ley et al. 
2007).  Next, intravascular crawling is mediated by beta2-integrin subunits, and finally, 
paracellular migration is advanced by beta1,2,3-integrin subunits (Ley et al. 2007). 
Specific integrin subunit involvement at critical points as the neutrophil leaves the 
bloodstream demonstrates the importance of neutrophil integrin-mediated adhesion in 
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regulating neutrophil chemotaxis.  In fact, data has shown that integrin-mediated 
interactions directly contribute to the migratory speed and capability of neutrophils 
(Berton et al. 1999).  At least three classes of tyrosine kinases have been implicated in 
outside in signaling in phagocytic cells; the FAK (focal adhesion kinase) family, the Src 
family, and the Syk family (Berton et al. 1999).  FAK, a crucial regulator of 
mesenchymal cell migration, is not expressed in all hematopoietic cells (Berton et al. 
1999).  Pyk2 (protein tyrosine kinase 2), the only other family member of the FAK 
family, is however, expressed in many hematopoietic cells, suggesting that it is important 
in outside in integrin signaling in hematopoietic cells (Berton et al. 1999).  The incoming 
data regarding integrin signaling emphasizes the notion that ECM/environmental 
signaling greatly influences the entire neutrophil chemotactic response.  
 
Neutrophil-like model 
Since neutrophils are short-lived, terminally differentiated cells that cannot be 
genetically manipulated, much of the research on neutrophil chemotaxis has been 
performed in the HL-60 cell line (Hauert et al. 2002).  HL-60 cells, a promyelocytic cell 
line, can be induced to differentiate into neutrophil-like cells (dHL-60 cells), in which 
they perform chemotaxis in response to chemoattractants, such as fMLP (formylated-
methionine-leucine-phenylalanine, a formylated peptide commonly used as a 
chemoattractant), much as primary neutrophils do, and have thus been deemed a valid 
model to study neutrophil chemotaxis (Hauert et al. 2002). 
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1.3.  Clinical Significance 
As previously mentioned, neutrophils are an integral part of our innate immune 
system, and in order to clear sites from infection, they must be able to functionally 
perform chemotaxis.  Despite the significance of matrix-specific substrate interaction in 
maintaining polarity and regulating chemotaxis, little is known about these signaling 
events and how they cooperate with the molecular programs that promote frontness and 
backness signaling in the cell.  Elucidating these molecular pathways will certainly 
uncover mechanistic details regarding potentially deadly neutrophil deficiency diseases, 
such as Leukocyte Adhesion Deficiency, in which neutrophils are lacking the beta2-
integrin subunit, and possibly incite new initiatives for clinical treatment. 
While neutrophils work to clear infection, an overactive neutrophil response can 
cause substantial tissue damage.  Chronic inflammation, in which healthy tissue is 
targeted and destroyed, is implicated in many diseases, such as rheumatoid arthritis, 
inflammatory lung disease, inflammatory bowel disease, atherosclerosis, and Crohn’s 
Disease.  Neutrophil cells may contribute to this process and a better understanding of the 
regulatory components in neutrophil chemotaxis may reveal elements that are essential 
for neutrophil migration, but dispensable for mesenchymal migration, and thus may 
provide novel therapeutic targets. 
Lastly, there is increasing evidence that chemoattractant receptors such as CCRs, 
CXCRs, and the fMLP receptor are involved in the metastasis of various cancers, such as 
breast cancer, melanoma, lung cancer, and squamous cell carcinomas (Muller et al.  
2001, Murakami et al. 2002, Spano et al. 2004).  In addition, metastatic cancer cells can 
undergo a mesenchymal - amoeboid transition, in which the cancer cells migrate, using 
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amoeboid molecular mechanisms which accelerate the metastatic process (Wolf et al. 
2003).  Therefore, expanded knowledge of chemoattractant-mediated signaling 
mechanisms and amoeboid migration processes will increase our understanding of cancer 
progression, and may offer innovative therapeutic options for the treatment of cancer.      
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1.4.  Figures 
 
 
Figure 1.1.  The migration cycle.  This multi-step progression can be conceptually 
thought of as a repeating cycle.  First, a protrusion extends from the cell.  Protruding 
membranes are driven by polymerization of the actin cytoskeleton.  Second, the 
protrusion at the front of the cell forms stable attachments to the substrate which are 
generally mediated by the integrin family of transmembrane receptors.  Next, the cell 
body translocates forward, and finally, the adhesion at the rear of the cell detaches, and 
the rear of the cell retracts which is accomplished by the contractility of the actin-myosin 
machinery (Web et al. 2002). 
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Figure 1.2.  Neutrophil signalling pathways that promote polarity.  The frontness 
pathway is mediated by the trimeric G protein, Gi (Xu et al. 2003).  Activated Gi produces 
3’-phosphoinositol lipids (PI3Ps), which in turn activates Rac, a small RhoGTPase, 
which thereby promotes actin polymerization.  (Xu et al. 2003, Srinivasan et al. 2003).  
Polymerizing actin acts in a positive feedback loop with PI3Ps and Rac to help organize 
the leading edge of cells (Srinivasan et al. 2003).  The backness pathway, on the other 
hand, is mediated by G12/13 (Xu et al. 2003).  G12/13 activates Rho, a small RhoGTPase, 
which activates ROCK, a Rho-dependent kinase, which finally activates myosin 
contractility at the trailing edge of the cells (Xu et al. 2003).  Mutual opposition between 
these assemblies induces them to separate from each other in the membrane (Xu et al. 
2003). 
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Figure 1.3.  The specific adhesion cascade neutrophils utilize to exit the bloodstream.  
The first events are capture of the neutrophils to the endothelial wall of the blood vessel, 
followed by rolling, and slow rolling.  These initial events are mediated by selectins, a 
family of cell adhesion glycoproteins.  The next important event is firm arrest which is 
ensued by beta1,2,7-integrin subunits.  Next, intravascular crawling is mediated by beta2-
integrin subunits, and finally, paracellular migration is advanced by beta1,2,3-integrin 
subunits (modified from Ley et al. 2007). 
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Chapter # 2:  The Non-Receptor Tyrosine Kinase Pyk2 Controls Rear Contraction 
in Migrating Neutrophil Cells by Regulating RhoA/p190RhoGEF Complex 
 
2.1.  Summary 
Neutrophils adopt a highly polarized morphology and integrate many matrix-
specific signals to undergo specialized migratory events to pursue invading pathogens.  
While these matrix-specific signaling events have emerged as crucial elements for proper 
migration and recruitment of neutrophil cells, the underlying signaling networks remain 
poorly defined.  Here we have identified Pyk2, a FAK (focal adhesion kinase) family 
non-receptor tyrosine kinase, as a beta2-integrin-dependent regulator of rear contraction 
in migrating neutrophil cells.  We show that Pyk2 is specifically activated by beta2-
integrin and that Pyk2 mediates contraction by interaction with p190RhoGEF and RhoA 
thereby regulating the myosin contractility at the rear of the cell.  These data elucidates a 
novel mechanism in which Pyk2 integrates matrix-specific substrate interaction with the 
signaling network responsible for the polarized morphology needed for neutrophil 
migration. 
 
2.2.  Introduction 
Migrating neutrophils exhibit a highly polarized morphology in which actin 
polymerization is localized to the leading edge (pseudopod), and activated myosin II is 
localized at the trailing edge (uropod) (Xu et al. 2003).  In order to maintain this polarity, 
these cells utilize a network of two distinct and divergent signaling pathways, the 
“frontness pathway” and the “backness pathway.” (Xu et al. 2003).  The frontness 
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pathway is mediated by the trimeric G protein, Gi (Xu et al. 2003).  Activated Gi 
produces 3’-phosphoinositol lipids (PI3Ps), which in turn activates Rac, a small 
RhoGTPase, which thereby promotes actin polymerization. (Xu et al. 2003, Srinivasan et 
al. 2003).  The backness pathway, on the other hand, is mediated by G12/13 (Xu et al. 
2003).  G12/13 activates Rho, a small RhoGTPase, which activates ROCK, a Rho-
dependent kinase, which finally activates myosin contractility at the trailing edge of the 
cells (Xu et al. 2003). 
These distinct and divergent signaling pathways, however, cannot completely 
explain persistent polarity and migration.  Stimulation of neutrophils with fMLP in 
suspension causes transient membrane extensions, but the actin-dependent polarity and 
frontness signals do not persist and decline 2–3 minutes after stimulation (Xu et al. 
2003).  This is in contrast to cells stimulated on ECM substrates, including intracellular 
adhesion molecule 1 (ICAM-1), fibrinogen, fibronectin, and vitronectin; these cells 
become highly polarized and migratory, even 10 minutes after stimulation with fMLP 
(Xu et al. 2003, Schymeinsky et al. 2006, Eddy et al. 2000).  
Furthermore, matrix-specific cues mediate specific migratory phases as 
neutrophils prepare to leave the bloodstream and migrate through the extracellular matrix.  
The early events, capture of the neutrophil to the endothelial wall of the blood vessel, 
followed by rolling, and slow rolling, are mediated by selectins, a family cell adhesion 
glycoproteins (Ley et al. 2007).  The next important event, firm arrest, is ensued by 
beta1,2,7-integrin subunits (Ley et al. 2007).  Next, intravascular crawling is mediated by 
beta2-integrin subunits, and finally, paracellular migration is advanced by beta1,2,3-
integrin subunits (Ley et al. 2007). 
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Despite the significance of matrix-specific substrate interaction in maintaining 
polarity and migration, little is known about these signaling events and how they 
cooperate with the divergent signaling pathways that promote polarity via actin 
polymerization at the front of the cell and myosin contraction at the back of the cell.  At 
least three classes of intracellular tyrosine kinases have been implicated in outside in 
signaling from integrins in phagocytic cells; the FAK (focal adhesion kinase) family, the 
Src family, and the Syk family (Berton et al. 1999).  Pyk2, a member of the FAK family, 
is expressed in many hematopoietic cells (Berton et al. 1999).  Pyk2 is known to bind to 
cytoskeleton associated proteins and is activated after integrin stimulation (Avraham et 
al. 2000).  Here we show that Pyk2 plays an important role as an integrin-dependent 
regulator of contractility at the rear of the cell. 
 
2.3.  Materials and Methods 
Reagents and plasmids 
Human fibrinogen, human serum albumin (HSA) and fMLP were from Sigma-
Aldrich. Y-27632 was from Calbiochem. Alexa fluor 488 phalloidin was from Invitrogen. 
ON-TARGETplus SMARTpool siRNAs, which contain four siRNAs specifically 
targeting human Pyk2, non-specific siRNAs and siGLO were from Dharmacon.  Pyk2 
antibody was from BD Bioscience.  Phospho-Pyk2 antibody was from Biosource.  
Phospho-myosin antibody was from Cell Signaling. Alpha-tubulin antibody was from 
abcam.  HA antibody was from Covance, GST antibody was from Santa Cruz 
Biotechnology, and RhoA antibody was from Cell Signaling.  The dominant negative 
mutant of Pyk2 (K457A) and wild type Pyk2 constructs were obtained from Kita Lab 
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(Yamasaki et al. 2001).  The GST-Rhotekin plasmid was from the Schwartz Lab (Ren et 
al. 1999).  Pyk2 targeting sequence (Pyk2 3’ UTR / 845 – forward, 
GACTTGTGGTTGAATTAAA) were annealed and cloned into pSicoR vectors for Pyk2 
knockdown.  The shRNA constructs targeting the human p190RhoGEF 
(TRCN0000265817, TRCN0000256483) was from Sigma.  
 
Cell culture, transient transfection, lentiviral production and infection 
Cultivation and differentiation of HL-60 cells were described previously (Wang et 
al., 2002).  Transient transfections of dHL-60 cells were as described (Shin et al., 2010).  
For lentiviral production, shRNA-containing plasmids were co-transfected with three 
packaging plasmids pPL1, pPL2 and pPL/VSVG (Invitrogen) into actively growing 
HEK293T cells.  After 3 days of transfection, supernatant containing lentiviral particles 
was concentrated using Lenti-X concentrator (Clontech) and added to growing HL-60 
cells in the presence of 10 μg/ml polybrene for 24 hours.  Pyk2 knockdown cells were 
enriched by cell sorter (Cytomation Plus, Dako) (for pSicoR constructs) or selected in the 
presence of 0.5 μg/ml puromycin for 2 weeks (for PLKO.1 constructs). 
 
Immunofluorescence, live-cell imaging, and western blotting 
Immunofluorescence analysis and the detection of F-actin of in dHL-60 cells and 
human neutrophils were as described (Shin et al., 2010), except that cells were plated on 
human fibrinogen-coated cover glasses (250 μg/ml) (Schymeinsky et al., 2005).  For live-
cell imaging, cells were plated on fibrinogen-coated surface for 10 minutes, washed 
briefly, and subsequently stimulated either with a uniform concentration of 100 nM 
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fMLP or a point source of 10 μM fMLP from a micropipette as described (Servant et al., 
2000).  DIC images, fluorescent images and combined DIC/fluorescence images were 
collected with a Zeiss 40X NA 1.30 Fluar DIC objective or 63X NA 1.4 Plan 
Apochromat DIC objective on a Zeiss Axiovert 200M microscope.  All images were 
collected with a cooled charge-coupled device camera (AxioCam MR3, Zeiss) and 
processed by the Image J program.  The procedures for western blotting were described 
previously (Shin et al., 2010). 
 
Microfluidic gradient device 
The microfluidic gradient device comprises of a polydimethylsiloxane (PDMS) 
slab embedded with a Y-shaped fluidic channel and glass substrate as its base.  The 
microchannels were fabricated using rapid prototyping and soft lithography as described 
previously (Herzmark et al., 2007; Jeon et al., 2000; Lin and Butcher, 2006).  Cells 
suspended in mHBSS containing 1% HSA were injected in the microfluidic device and 
allowed to attach to the fibrinogen substrate (20 minutes).  The channels were then gently 
rinsed with mHBSS to wash away floating cells.  To generate soluble gradients, fMLP 
(500 nM) and mHBSS were infused into the device from separate inlets.  Solutions were 
driven using a syringe infusion pump (Pump 22, Harvard Apparatus) at a flow rate of 
0.03 ml/h to generate a concentration gradient in the channel by diffusion. Images were 
captured using the Axiovision software (Zeiss).  Cell movement and speed were analyzed 
using Cell Track (Sacan et al. 2008). 
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GST-Rhotekin assay 
Cells (5 x 106) were suspended or cells (10 x 106) were adhered to FG-coated 
glass plates in 90 μl of mHBSS buffer (20 mM HEPES, pH 7.4, 50 mM sodium chloride, 
4 mM potassium chloride, 1 mM magnesium chloride, 10 mM glucose) and stimulated 
with 10 μl of 1 μM fMLP for various times. fMLP stimulation was terminated by the 
addition of 3.8% paraformaldehyde for 10 min. at room temperature.  Cells were then 
treated with 0.2% Triton X-100 for 5 min. at room temperature.  Cells were then blocked 
with 5% nonfat dry milk for an hour at room temperature and incubated with purified 
GST-Rhotekin overnight at 4°C.  Samples were then washed three time with ice cold 
PBS and used for either western analysis or immunostaining. 
 
Production and isolation of GST-Rhotekin 
The coding sequence for the Rho-binding domain of Rhotekin (amino acids 7–89) 
was cloned into the bacterial expression vector pGEX-4T3 and pGEX-2T, respectively, 
and was expressed in Escherichia coli as a fusion protein with glutathione S-transferase.  
The purified fusion proteins were isolated from glutathione-Sepharose beads with 10 mm 
reduced glutathione and stored at −80°C in 25 mm Tris-HCl, pH 7.5, 0.2m DTT, 1 mm 
MgCl2, and 5% glycerol. 
 
Pyk2 immunoprecipitation 
Cells (5 x 106) were suspended or cells (10 x 106) were adhered to FG-coated glass 
plates in 90 μl of mHBSS buffer (20 mM HEPES, pH 7.4, 50 mM sodium chloride, 4 mM 
potassium chloride, 1 mM magnesium chloride, 10 mM glucose) and stimulated with 10 μl 
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of 1 μM fMLP for various times.  fMLP stimulation was terminated by the addition of 400 
μl of 1.25 x RIPA buffer (50 mM Tris-HCl, pH 7.5, 1% NP-40, 150 mM NaCl, 1 mM 
EDTA) containing 1 mM Na3VO4, 1 mM NaF, 1 mM PMSF and a protease inhibitor 
cocktail (Sigma).  Adhered cell were scraped using a cell scraper.  After centrifugation at 
14,000 x g for 10 min, cell lysates were incubated with 2 µg of anti-Pyk2 antibody.  After 
2 h of incubation at 4ºC, protein A beads were added to the cell lysates.  The resulting 
immunoprecipitates were washed with ice-cold RIPA buffer and analyzed further with 
SDS-PAGE. 
 
2.4.  Results 
Pyk2 is activated by fMLP and beta2-integrin. 
In order to explore the role of Pyk2 in neutrophils, we assessed the localization of 
Pyk2 in the neutrophil-like cell line, differentiated HL-60 cells (dHL-60), and primary 
neutrophils.  HL-60 cells, a promyelocytic cell line widely used to study neutrophil 
polarity and chemotaxis, can be induced to differentiate into neutrophil-like cells (dHL-
60 cells) which polarize and migrate in response to chemoattractants much like primary 
neutrophils do (Hauert et al. 2002, Wang et al. 2002, Xu et al. 2003).  However, these 
cells, unlike primary neutrophils, are immortalized in culture and can be genetically 
manipulated (Wang et al. 2002, Xu et al. 2003, Srinivasan et al. 2003).   
In fixed cells stimulated with chemoattractant fMLP, Pyk2 localizes to the leading 
edge of dHL-60 cells, but is also present throughout the cytoplasm (Figure 2.1a).  dHL-
60 cells transfected with a plasmid containing the cloned Pyk2 gene fused to the GFP 
gene (Pyk2-GFP) and stimulated with a gradient of fMLP delivered by a micropipette 
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also exhibited recruitment of Pyk2-GFP to the leading edge of the cell, as well as a 
continued presence in the cytoplasm (Figure 2.1b). 
Phosphorylation of residue tyrosine 401 is the first step in the activation of Pyk2 
(Park et al. 2004).  The activity of Pyk2 was analyzed using an antibody to tyrosine 402 
and Pyk2 was found to be rapidly phosphorylated in cells stimulated with fMLP (Figure 
2.1c), indicating rapid activation of Pyk2.  Importantly, Pyk2 has been reported to be 
activated upon beta2-integrin binding, and blocked by pre-incubation with IB4 in HL-60 
cells, primary neutrophils, and other leukocyte cells (Yan et al. 1999, Miura et al. 2000, 
Duong et al. 2000).  Moreover, upon fMLP stimulation, Pyk2 has been shown to 
associate with beta2-integrin (Miura et al. 2000).  So we next assessed the levels of active 
Pyk2 in cells plated on beta2-integrin substrate, fibrinogen (FG).  Active Pyk2 was indeed 
detected in un-stimulated cells plated on FG (Figure 2.1d).  Also, beta2-integrin function-
blocking antibody (IB4) almost completely abolished Pyk2 phosphorylation in cells that 
had been plated on FG (Figure 2.8a).  Consequently, our results, along with others point 
towards an outside-in transduction of Pyk2, mediated by beta2-integrin. 
 
Pyk2 depletion impairs chemotaxis on beta2-integrin ligands. 
To elucidate the role of Pyk2 in neutrophil migration, we developed a lentivirus-
based system to stably express Pyk2 targeting small hairpin RNAs (shRNAs) in dHL-60 
cells (Pyk2-shRNA expressing cells), which allows us to conduct large-scale biochemical 
analyses.  Using this technique, we achieved high levels of Pyk2 knockdown in four 
different constructs (Figure 2.2a,b, 2.9a).  When Pyk2-shRNA expressing cells were 
plated on FG they exhibited a very apparent and severe phenotype, resulting in multiple, 
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simultaneous leading edges and long, stretched trailing edges (Figure 2.2c, 2.9b).  As a 
negative control, HL-60 cells were stably infected with the pLKO.1 vector expressing 
non-targeting shRNAs or the pSicoR vector (NT shRNA control cells or pSicoR control 
cells).  These control cells migrated with normal polarity and morphology (Figure 2.2c, 
2.9b).  Importantly, we observe these morphological defects in Pyk2-shRNA expressing 
cells plated on FG even before stimulation with fMLP (Figure 2.2c), indicating that beta2-
integrin outside-in transduction of Pyk2 is necessary for proper polarization and 
migration on FG. 
Pyk2-shRNA expressing cells exhibited a ~50% reduction in cellular velocity 
(1.73 μm/min ± 0.30) as compared to pSicoR control cells (3.27μm/min ± 0.50) and dHL-
60 cells (3.61 μm/min ± 0.39) (Figure 2.9c).  Pyk2-shRNA expressing cells also exhibited 
an elongation index (the ratio of the length of a polarized cell when fully extended to the 
width of its pseudopod) of near twice the value (3.12 ± 0.17) than that of the pSicoR 
control cells (1.58 ± 0.46) and dHL-60 cells (1.88 ± 0.17) (Figure 2.9d), indicating the 
severity of the long tail.  As a measure of the propensity to exhibit multiple leading edges 
and projections, Pyk2-shRNA expressing cells, on average, gave rise to near double the 
number of membrane protrusions (2.07 ± 0.37) than that of the pSicoR control cells (1.18 
± 0.10) and dHL-60 cells (1.17 ± 0.05) (Figure 2.9e). 
We also utilized a microfluidic gradient-making device which allowed us to 
watch populations of cells move in highly stable gradients over a long distance.  Pyk2-
shRNA expressing cells showed a large reduction in migration in the device when coated 
with FG (Figure 2.2d).  While this assay is not designed to analyze detailed 
morphological impairments in the cell, it is notable that Pyk2-shRNA expressing cells 
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exhibited multiple protrusions and long tails (Figure 2.2d).  When measured, Pyk2-
shRNA expressing cells migrated around only half the total distance of pSicoR control 
cells (365.02 ± 2.05 pixels, 158.13 ± 1.32 pixels respectively) (Figure 2.9f, Sacan et al. 
2008), and migrated at near half the speed of pSicoR control cells (2.05 ± 0.10 
pixels/fame, 1.33 ± 0.07 pixels/frame respectively) (Figure 2.9g, Sacan et al. 2008).  This 
is consistent with the velocity studies performed using the micropipette migration assay 
(Figure 2.9c). 
We also knocked down the expression of Pyk2 using a pool of siRNAs that target 
human Pyk2.  Transfection of dHL-60 cells with the Pyk2 targeting-siRNAs caused 
~80% reduction of Pyk2 protein expression as compared to cells transfected with non-
targeting siRNAs after 48 hr (Figure 2.9h).  The Pyk2-siRNA-transfected cells exhibited 
the same migratory phenotype with multiple leading edges and stretched trailing edges 
(Figure 2.9i).  Transfection efficiency of the siRNAs was monitored by co-transfection 
with a fluorescently labeled oligo (siGlo) at a significantly lower concentration than the 
non-targeting siRNA and the Pyk2-siRNA.  siGlo was consistently observed at a high 
transfection efficiency (data not shown). 
We also perturbed Pyk2 function by using a dominant negative mutant.  dHL-60 
cells transfected with a DNA construct coding for a kinase dead mutant (K457A) of Pyk2 
fused to GFP (GFP-Pyk2-K457A) exhibited the same migratory phenotype with multiple 
leading edges and long trailing edges (Figure 2.9j).  To control for the effects of the GFP 
fusion and the effects of overexpression we performed the same assay with the GFP-Pyk2 
construct and GFP-Pyk2-transfected cells migrated with normal polarity and morphology 
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(Figure 2.9j).  These data indicate the need for Pyk2 kinase activity to maintain proper 
neutrophil polarity and migration. 
Lastly, we also utilized small molecule inhibitors to confirm the migratory defect.  
The small molecule inhibitor, PF-562,271, is a dual Pyk2/FAK inhibitor, while PF-
573,228 is a FAK-specific inhibitor (Slack-Davis et al. 2007, Roberts et al. 2008).  Since 
FAK is not expressed in dHL-60 cells (data not shown), PF-562,271 was used as a Pyk2-
specific inhibitor and PF-573,228 was used as a negative control in dHL-60 cells.  As 
expected, PF-562,271-treated cells exhibited multiple leading edges and long trailing 
edges when plated on FG (Figure 2.9c), while PF-573,228-treated cells migrated with 
normal morphology (Figure 2.9c). 
 
Pyk2 depletion impairs RhoA activity and myosin activity in cells migrating on 
beta2-integrin ligands. 
It did not escape our attention that the morphological defect observed in Pyk2-
depleted cells is exceedingly similar to the defect observed in cells in which components 
of the backness pathway have been perturbed.  Perturbing any of the components of the 
myosin contractility pathway at the back of the cell elicits a very distinct phenotype (Xu 
et al. 2003).  These cells develop long tails because the cells are not able to contract and 
detach their trailing edge (Xu et al. 2003).  These cells also develop multiple leading 
edges due to lack of actin protrusion inhibition (Xu et al. 2003). 
A side by side comparison of cells treated with Y-27632 (an inhibitor to ROCK) 
with DN-Pyk2-GFP-transfected dHL-60 cells confirmed this strong resemblance (Figure 
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2.10a).  Both Y-27632-treated dHL-60 cells and DN-Pyk2-GFP-transfected dHL-60 cells 
plated on FG give rise to multiple leading edges and long tails (Figure 2.10a). 
The matching migratory defects lead us to test for potential impairments in the 
backness pathway in Pyk2-depeleted cells.  RhoA is well known to receive signals from 
integrin (Williams et al. 1999, Dib et al. 2001, Zhai et al. 2003).  Accordingly, in order to 
test for RhoA activity, we developed an assay in which we used GST-Rhotekin as a probe 
for active RhoA in fixed cells adhered to FG.  After probing with GST-Rhotekin, we 
either lysed cells for large scale biochemical analysis or immunostained fixed cells to 
observe sub-cellular localization on a single cells basis.  Using this technique, we 
determined that the levels of active RhoA in Pyk2-shRNA cells were decreased by over 
60% as compared to RhoA levels in pSicoR control cells (Figure 2.3a).  The decrease in 
Rho activity was also observed via cell staining; Pyk2-shRNA cells showed a stark 
decrease in GST staining as compared to pSicoR control cells (Figure 2.3b).  Also, 
importantly, GST staining in Pyk2-shRNA cells did not localize to the back and sides of 
the cells as did in pSicoR control cells, indicating a mis-localization of active RhoA 
(Figure 2.3b). 
We repeated these experiments in 293T cells by transfecting with either a DNA 
construct coding for full length Pyk2 fused to GFP (GFP-Pyk2) or a kinase dead mutant 
(K457A) of Pyk2 fused to GFP (GFP-Pyk2-K457A).  We also observed a decrease in 
Rho activity in GFP-Pyk2-K457A transfected cells as compared to GFP-Pyk2 transfected 
cells (Figure 2.3c), suggesting that the kinase activity of Pyk2 is also crucial for the 
activation of RhoA.   
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To further test the integrity of the backness pathway in Pyk2-depleted cells, we 
assessed the levels of phospho-myosin II in fMLP-stimulated cells plated on FG.  As 
expected, in dHL-60 cells, phospho-myosin II was significantly localized to the trailing 
edge of the cell, while the phospho-myosin II staining in Y-27632-treated cells was 
almost completely abolished, and did not show localization at the rear of the cell (Figure 
2.3d,e).  Phospho-myosin II staining in the DN-Pyk2-GFP-transfected cells was also 
severely disrupted, exhibiting a distinct lack of backness localization and an overall 
decrease in staining intensity (Figure 2.3d,e).  DN-Pyk2-GFP transfected cells exhibited a 
near 40% decrease in staining intensity as compared to the control cells (Figure 2.10b).  
Taken together, the decrease in RhoA activity and phospho-myosin levels in Pyk2-
depleted cells implicates Pyk2 as a regulator of the backness pathway in migrating cells. 
 
p190RhoGEF depletion impairs chemotaxis on beta2-integrin ligands. 
How is Pyk2 involved in RhoA activation?  p190RhoGEF (Rgnef), a 190kDa 
guanine exchange factor, has recently been implicated as an important player in fibroblast 
migration.  In fibroblasts, p190RhoGEF knockdown has been shown to inhibit RhoA 
activation, focal adhesion formation, and cell migration on FN (Lim et al. 2008).  Also, 
fibroblasts from p190RhoGEF knockout mice showed inhibited migration, focal adhesion 
number, and RhoA GTPase activation after integrin stimulation (Miller et al. 2012).   
Furthermore, p190RhoGEF has been shown to interact directly with the FAT 
(focal adhesion targeting) domain of FAK, which is a conserved domain in Pyk2 (Zhai et 
al. 2003, Avraham et al. 2000).  FAK was shown to enhance p190RhoGEF tyrosine 
phosphorylation, acting to coordinate RhoA activation in neuronal cells (Zhai et al. 
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2003).  This supports the notion that FAK’s association with p190RhoGEF functions as a 
signaling pathway downstream of integrins to stimulate Rho activity (Zhai et al. 2003). 
Using the same lentivirus-based system to stably express Pyk2 targeting shRNAs 
in dHL-60 cells, we stably expressed two different p190RhoGEF targeting shRNAs in 
dHL-60 cells (p190RhoGEF-shRNA expressing cells).  We were able to achieve a high 
level of p190RhoGEF knockdown as shown by immunofluorescence (Figure 2.4a).  We 
were unable to obtain an antibody to detect p190RhoGEF levels via western analysis, 
however, we were able to show ~80% knockdown via cell staining (Figure 2.4b). 
Importantly, p190RhoGEF-shRNA expressing cells share the same migration 
impediments asPyk2-depleted cells (Figure 2.4c).  As shown with the micropipette 
migration assay, these cells also have long stretched trailing edges and multiple leading 
edges (Figure 2.4c).  p190RhoGEF-shRNA expressing cells, like the Pyk2-shRNA 
expressing cells, show a large decease in cell velocity (Figure 2.11a).  p190RhoGEF-
shRNA expressing cells and the Pyk2-shRNA expressing cells also share similarly 
increased elongation indexes as well as a similarly high number of protrusions (Figure 
2.11b,c).  We also tested these cells in the microfluidic gradient-making device.  As 
expected, p190RhoGEF-shRNA expressing cells exhibited a large decrease in overall 
migration (Figure 2.4d). 
 
p190RhoGEF depletion impairs RhoA activity and myosin activity in cells 
migrating on beta2-integrin ligands. 
Using the GST-Rhotekin technique described previously, we assessed the relative 
levels of RhoA in p190RhoGEF-shRNA expressing cells.  As expected, these cells 
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showed a near 60% decrease in RhoA activity as compared to the NT shRNA control 
cells (Figure 2.5a).  A large decrease in RhoA activity is also seen via cells staining 
(Figure 2.5b).  Importantly, we also observe a disruption in the localization pattern of 
RhoA activity (Figure 2.5b).  While active RhoA localized to the back and sides of the 
NT shRNA control cells, it was largely mis-localized in p190RhoGEF-shRNA expressing 
cells (Figure 2.5b). 
p190RhoGEF-shRNA expressing cells also exhibit decreased levels of phospho-
myosin as shown by immunofluorescence (Figure 2.5c).  There was also a mis-
localization of phospho-myosin in p190RhoGEF-shRNA expressing cells; just as the 
Pyk2-shRNA cells exhibit a loss of staining at the rear of the cell, p190RhoGEF-shRNA 
expressing cells also exhibit decreased staining at the rear, indicating p190RhoGEF-
shRNA expressing cells also contain perturbed backness signals. 
 
Pyk2 kinase activity promotes interaction with RhoA and p190RhoGEF. 
We next wanted to test for potential interactions between Pyk2 and RhoA and 
between Pyk2 and p190RhoGEF.  Since we observe decreases in RhoA and myosin 
activity in Pyk2-depleted cells and in p190RhoGEF-depleted cells and since we see the 
same apparent morphological defect in contraction in both Pyk2-depleted cells and 
p190RhoGEF-depleted cells, we suspected that Pyk2, p190RhoGEF, and/or RhoA may 
associate with one another.  In order to assess potential interactions between RhoA and 
Pyk2, we performed co-immunoprecipitation.  We found Pyk2 and RhoA to consistently 
co-immunoprecipitate in stimulated dHL-60 cells adhered to FG (Figure 2.6a).  We also 
tested this interaction in 293T cells transfected with GFP-Pyk2 and GFP-Pyk2-K457A.  
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In 293T cells, Pyk2-GFP consistently co-immunoprecipitated with RhoA (Figure 2.6b).  
GFP-Pyk2-K457A, however, failed to strongly interact with RhoA (Figure 2.6b), 
indicating the significance of the kinase activity of Pyk2 in this interaction.  Also, 
notable, the interactions being present in 293T cells suggest that the role of Pyk2 in RhoA 
activation may be a more general signaling network than previously considered. 
Next, we tested potential interactions between Pyk2 and p190RhoGEF.  In 293T 
cells co-transfected with DNA construct GFP-Pyk2 and DNA construct coding for full 
length p190RhoGEF fused to HA (HA-p190RhoGEF), GFP-Pyk2 consistently co-
immunoprecipitated with HA-p190RhoGEF (Figure 2.6c).  Also we observed a strong 
decrease in this interaction when we performed this experiment with GFP-Pyk2-K457A 
construct (Figure 2.5a), indicating that p190RhoGEF and Pyk2 interact, and this 
interaction is enhanced though the kinase activity of Pyk2. 
 
2.5.  Discussion 
We have identified Pyk2 as a beta2-integrin-dependent regulator of rear 
contraction in migrating neutrophil cells.  Pyk2 is activated by both fMLP simulation as 
well as by cell interaction with beta2-integrin indicating that it is involved in both inside-
out and outside-in signaling in migrating neutrophil cells.  Depletion of Pyk2 causes a 
severe morphological defect that is exceedingly similar to the defect observed in cells in 
which components of the backness pathway have been perturbed.  Furthermore, we have 
shown that Pyk2 depletion causes a decrease in RhoA activity and myosin activity.  This 
is consistent with previous studies using cells from Pyk2 knockout mice.  Neutrophils 
from Pyk2 knockout mice also exhibit decreased migration in beta2-integrin coated 
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transwells (Kamen et al. 2013), and macrophages from Pyk2 knockout mice also exhibit 
decreased migration and multiple leading edges along with decreased contractile activity 
and decreased RhoA activity (Okigaki et al. 2003).    
This indicates that Pyk2 is regulating the rear contraction pathway in migrating 
neutrophil cells.  It is known that neutrophil cells utilize two divergent pathways to 
establish polarity, one to promote actin polymerization the front of the cell and one to 
promote actin-myosin contraction at the rear of the cell (Xu et.al. 2003).  And while it is 
known that migrating neutrophil cells need matrix-specific signaling to maintain polarity 
and migration, little is known about exactly how migrating neutrophil cells integrate their 
matrix-specific signals with signals that are promoting their persistent polarity.  We have 
shown that Pyk2 is able to do this by receiving upstream signaling from beta2-integrin, 
and by also regulating the contraction at the rear of the cell. 
Beta2-integrin is an important and specific upstream regulator of Pyk2.  When we 
plate Pyk2-depleted cells on fibronectin, a beta1-integrin ligand, we did not observe the 
same morphological defect (Figure 2.12).  These cells appeared to have a mild defect in 
maintaining persistent polarity.  Importantly, however, they did not exhibit the same 
phenotype as seen in Pyk2-depleted cells plated on fibrinogen, a beta2-integrin ligand 
(Figure 2.12).  Also, we observe a strong interaction between Pyk2 and RhoA via co-
immunoprecipitation in cells plated on FG, yet this interaction does not occur in cells 
plated on FN (Figure 2.6a).  Lastly, we do not observe a decrease in phospho-myosin 
staining in Pyk2-depleted cells plated on FN, while we do in Py2-depleted cells plated on 
FG (Figure 2.12b).  This indicates that Pyk2 is differentially integrating upstream matrix-
specific signaling.  The decrease in Pyk2-RhoA interaction and rear contraction observed 
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in Pyk2-depleted cells is specific to upstream signaling from beta2-integrin.  This is also 
consistent with previous studies using neutrophils from Pyk2 knockout mice.  
Neutrophils from Pyk2 knockout mice have decreased migration in beta2-integrin coated 
transwells, however, they are able to migrate as well as wildtype PMNs in uncoated 
transwells (Kamen et al. 2013). 
We have shown that Pyk2-depleted cells exhibit a decrease in RhoA activity and 
in myosin activity at the rear of the cell.  How does Pyk2 regulate this activity?  We 
showed that p190RhoGEF (Rgnef), a 190kDa guanine exchange factor that has recently 
been implicated as an important player in fibroblast migration, to be a key player in this 
signaling pathway.  We show that p190RhoGEF-depleted cells exhibit the same 
morphological defect as Pyk2-depleted cells as well as a decrease in RhoA activity and a 
decrease in myosin activity at the rear of the cell.  This is consistent with previous studies 
where, in fibroblasts, p190RhoGEF knockdown has been shown to inhibit RhoA 
activation (Lim et al. 2008).  Also, fibroblasts from p190RhoGEF knockout mice showed 
inhibited RhoA GTPase activation after integrin stimulation (Miller et al. 2012). 
Furthermore, we show that Pyk2 interacts with p190RhoGEF and also with RhoA 
in neutrophils cells adhered to beta2-integrin ligands.  This indicates that Pyk2, 
p190RhoGEF, and RhoA are working together in a potential complex to regulate the 
contraction at the rear of the cell.  Upon fMLP stimulation, the Gi-mediated frontness 
pathway promotes actin polymerization at the front of the cell and the G12/13-mediated 
pathway promotes actin-myosin contraction at the back of the cell.  We theorize that 
simultaneously Pyk2 is activated by both fMLP and independently by beta2-integrin.  
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Activated Pyk2 then interacts with p190RhoGEF and RhoA to promote actin-myosin 
contraction at the rear of the cell (Figure 2.7). 
How exactly does Pyk2 facilitate the activation of p190RhoGEF and Rho?  
Interestingly, we show that the interaction of Pyk2 with p190RhoGEF and with RhoA is 
strengthened by the kinase activity of Pyk2 (Figure 2.6b, c).  The interaction is severely 
diminished in samples transfected with a kinase dead construct of Pyk2 (Figure 2.6b, c).  
This indicates that the kinase activity is promoting interaction and that the active form of 
Pyk2 more readily associates with p190RhoGEF and with RhoA.  We also show that the 
activity of RhoA is strongly enhanced via the kinase activity of Pyk2 (Figure 2.3c).  
There is a strong decrease in levels of active RhoA in samples transfected with the kinase 
dead construct of Pyk2 as compared to samples transfected with full length Pyk2 (Figure 
2.3c).  It is possible that Pyk2 directly activates p190RhoGEF which thereby activates 
RhoA.  However, it is possible that Pyk2 also recruits other signaling machinery to the 
same complex. 
Syk is a non-receptor tyrosine kinase that has recently been found necessary to 
maintain neutrophil polarity (Schymeinsky et al. 2006).  Neutrophils from mice with 
reconstituted Syk knockout bone marrow exhibit severe migration defects in which they 
exhibit multiple leading edges on beta2-integrin ligands (Schymeinsky et al. 2006).  We 
also observed multiple leading edges and long trailing edges in stimulated dHL-60 cells 
treated with piceatannol, an inhibitor specific to Syk (data not shown).  Furthermore, Syk 
is constitutively associated with beta2-integrin, and Pyk2 becomes associated with beta2-
integrin upon fMLP stimulation (Muira et al. 2000).  Also, both Syk and Pyk2 experience 
enhanced tyrosine phosphorylation upon association with beta2-integrin (Muira et al. 
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2000).  It is possible that Pyk2 is working with Syk to regulate this potential 
Rho/p190RhoGEF complex. 
While these studies are intriguing, it is possible that Pyk2 also recruits adaptor 
molecules to facilitate signaling.  Cas-L, a lymphocyte and epithelial-specific isoform of 
p130Cas known to be involved in integrin signaling, was recently shown to be expressed 
in neutrophils (Nakamoto et al. 2008).  In neutrophils, Cas-L is phosphorylated upon 
stimulation with fMLP and the phosphorylation levels remain for longer time periods 
when bound to ECM ligands, including FG (Nakamoto et al. 2008).  Furthermore, Pyk2 
is known to associate with p130Cas in B cells and is thought to serve as a docking protein 
to bring various potential substrates within proximity of Pyk2 (Astier et al. 1997).  Future 
experiments will elucidate the exact mechanism by which Pyk2 facilitates the activation 
of p190RhoGEF and RhoA. 
The components of this pathway are likely confined to the rear of the cell.  We do 
observe Pyk2 staining throughout the entire cell; however, we also observe a slightly 
elevated localization of Pyk2 at the front of the cell.  Notably, this is not staining of 
phospho-Pyk2.  The localization pattern of active Pyk2 may reveal a different pattern.  
We suspect that an experiment to determine the localization of active Pyk2 would reveal 
a pool of active Pyk2 at the rear of the cell.  Our antibodies to phospho-Pyk2 were not 
suitable for immunostaining.  However, it would be interesting to use a Pyk2 biosensor in 
live cells to determine the levels and localization of Pyk2 activity in real time. 
Our results have identified Pyk2 as a beta2-integrin-dependent regulator of rear 
contraction in migrating neutrophil cells.  Pyk2 is specifically activated by beta2-integrin 
and mediates contraction by interaction with p190RhoGEF and RhoA thereby regulating 
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the myosin contractility at the rear of the cell.  These data elucidates a novel mechanism 
in which Pyk2 integrates matrix-specific substrate interaction with the signaling network 
responsible for the polarized morphology needed for neutrophil migration. 
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2.6.  Figures 
 
 
Figure 2.1.  Pyk2 is activated by fMLP and beta2-integrin.  (A) Immunostaining of 
Pyk2 in fMLP stimulated dHL-60 cells fixed with paraformaldehyde.  (B) Images from 
time-lapse micropipette migration assay of Pyk2-GFP-transfected dHL-60 cells.  (C) Cell 
lysates of dHL-60 cells from time course stimulation with 100nM fMLP probed for 
phosphor-Pyk2 and Pyk2.  (D) Western analysis of cell lysates from a time course of 
dHL-60 cells plated on FG and probed for phosphor-Pyk2.  Scale bars = 10μm. 
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Figure 2.2. 
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Figure 2.2 (continued).  Pyk2 depletion impairs chemotaxis on Beta2-integrin 
Ligands.  (A) Western analysis of cell lysates from dHL-60 cells, pSicoR control cells, 
and Pyk2-shRNA-expressing cells.  Tubulin is used as a loading control.  (B) Quantified 
western analysis using ImageJ.  (C) Images from time-lapse micropipette migration 
assay of pSicoR control cells and shPyk2-expressing cells plated on FG.  (D) Images 
from time-lapse microfluidic assay of pSicoR control cells and shPyk2-expressing cells 
plated on FG.  Scale bars = 50μm. 
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Figure 2.3. 
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Figure 2.3 (continued). 
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Figure 2.3 (continued). 
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Figure 2.3 (continued).  Pyk2 deplection impairs RhoA activity and myosin activity 
in cells migrating on beta2-integrin ligands.  (A) Western analysis of lysates from 
fixed cells adhered to FG and probed with GST-Rhotekin (blotted for GST) and lysates 
of cells adhered to FG (blotted for RhoA).  ImageJ quantificatn, n=7 and n=3, 
respectively.  (B) Immunostaining of paraformaldehyde-fixed, fMLP-stimulated pSicoR 
control cells and Pyk2-shRNA-expressing cells plated on FG, probed with GST-Rhotekin 
and staned for GST and phalloidin.  ImageJ analysis of GST pixel intensity across cell 
body of paraformaldehyde-fixed, fMLP-stimulated pSicoR control cells and shPyk2 cells 
plated on FG, probed with GST-Rhotekin and stained for GST and aphalloidin.  (C) 
Western analysis of lysates from fixed 293T cells transfected with Pyk2 constructs 
probed with GST-Rhotekin (blotted for GST) and lysates of 293T cells transfected with 
Pyk2 constructs (blotted for Pyk2 and RhoA).  ImageJ quantification, n=4, n=3, n=4, 
respectively.  (D) Immunostaining of paraformaldehyde-fixed, fMLP-stimulated dHL-60 
cells, Y-27632-treated dHL-60 cells, and Pyk2-shRNA-expressing cells plated on FG, 
probed for phospho-mysoin II and stained with phalloidin.  (E) ImageJ analysis of 
phospho-myosin pixel intensity across cell body of paraformaldehyde-fixed, fMLP-
stimulated dHL-60 cells, Y-27632-treated dHL-60 cells, and Pyk2-shRNA-expressing 
cells plated on FG.  Scale bar = 10μm. 
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Figure 2.4. 
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Figure 2.4 (continued).  p190RhoGEF depletion impairs chemotaxis on beta2-
integrin ligands.  (A) Immunostaining of paraformaldehyde-fixed, fMLP-stimulated NT 
shRNA control cells and p190RhoGEF-shRNA expressing cells plated on FG, probed for 
p190RhoGEF and stained with phalloidin.  (B) ImageJ analysis of overall phospho-
myosin pixel intensity of paraformaldehyde-fixed, fMLP-stimulated NT shRNA control 
cells and p190RhoGEF-shRNA expressing cells plated on FG.  Scale bar = 10μm.  (C) 
Images from time-lapse micropipette migration assay of p190RhoGEF-shRNA-
expressing cells plated on FG.  (D) Images from time-lapse microfluidic assay of pSicoR 
cells and p190RhoGEF-shRNA-expressing cells plated on FG. 
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Figure 2.5. 
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Figure 2.5 (continued).  p190RhoGEF depletion impairs RhoA activity and myosin 
activity in cells migrating on beta2-integrin ligands.  (A) Western analysis of lysates 
from fixed cells adhered to FG and probed with GST-Rhotekin (blotted for GST) and 
lysates of cells adhered to FG (blotted for RhoA).  ImageJ quantification, n=3 and n=3, 
respectively.  (B) Immunostaining of paraformaldehyde-fixed, fMLP-stimulated pSicoR 
control cells, Pyk2-shRNA-expressing cells, and p190RhoGEF-shRNA-expressing cells 
plated on FG, probed with GST-Rhotekin and stained for GST and phalloidin.  ImageJ 
analysis of GST pixel intensity across cell body.  (C) Immunostaining of 
paraformaldehyde-fixed, fMLP-stimulated pSicoR control cells, Pyk2-shRNA-expressing 
cells, and p190RhoGEF-shRNA-expressing cells plated on FG, probed for phospho-
myosin II and stained with phalloidin.  ImageJ analysis of phospho-myosin pixel intensity 
across cell body.  Scale bars = 20μm. 
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Figure 2.6.  Pyk2 kinase activity promotes interaction with RhoA and 
p190RhoGEF.  (A) Western analysis of immunoprecipitation of Pyk2 from dHL-60 cells 
adhered to FN and FG probed for Pyk2 and RhoA.  (B) Western analysis of 
immunoprecipitation of Pyk2 in 293T cells transfected with either GFP-Pyk2 or GFP-
Pyk2-K457A probed for Pyk2 and RhoA.  (C) Western analysis of immunoprecipitation of 
Pyk2 from 293T cells transfected with HA-p190RhoGEF and either GFP-Pyk2 or GFP-
Pyk2-K457A probed for Pyk2 and HA. 
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Figure 2.7.  Pyk2 as a beta2-integrin regulator of rear contraction in migrating 
neutrophils cells.  Pyk2 is activated by both fMLP and independently by beta2-integrin.  
Activated Pyk2 then interacts with p190RhoGEF and RhoA to promote actin-myosin 
contraction at the rear of the cell. 
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Figure 2.8.  (A) Western analysis of cell lysates of dHL-60 cells plated on FG and FN 
and treated with or without IB4 and probed for phospho-Pyk2.  Tubulin is used as a 
loading control. 
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Figure 2.9. 
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Figure 2.9 (continued). 
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Figure 2.9 (continued). 
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Figure 2.9 (continued).  (A) Western analysis of cell lysates from four different Pyk2-
shRNA-expressing dHL-60 cell lines.  Tubulin is used as a loading control.  (B) Images 
from time-lapse micropipette migration assay of four different Pyk2-shRNA-expressing 
cells plated on FG.  Scale bar = 10μm.  (C) Cell velocity measured inμm/min of dHL-60 
cells, pSicoR control cells, and Pyk2-shRNA-expressing cells in micropipette migration 
assay plated on FG.  (D) Stretch index as measured by cell length divided by cell width 
of dHL-60 cells, pSicoR control cells, and Pyk2-shRNA-expressing cells in micropipette 
migration assay plated on FG.  (E) Number of membrane protrusion exhibited by dHL-60 
cells, pSicoR control cells, and Pyk2-shRNA-expressing cells in micropipette migration 
assay plated on FG.  (F) Average total distance of pSicoR control cells and Pyk2-
shRNA-expressing cells in microfluidic migration assay plated on FG measured in pixels 
by Cell Track software.  (G) Average total speed of pSicoR control cells and Pyk2-
shRNA-expressing cells in microfluidic migration assay plated on FG measured in 
pixels/frame by Cell Track software.  (H) Western analysis of cell lysates from dHL-60 
cells transfected with NT siRNAor Pyk2-targeting siRNA, 48 hours, probed for Pyk2.  
Tubulin is used as a loading control.  (I) Images from time-lapse micropipette migration 
assay of NT siRNA-transfected dHL-60 cells and Pyk2-targeting siRNA-transfected 
dHL-60 cells plated on FG.  (J) Images from time-lapse micropipette migration assay of 
GFP-Pyk2-transfected dHL-60 cells and GFP-Pyk2-K457A-transfected dHL-60 cells 
plated on FG.  (K) Images from time-lapse micropipette migration assay of PF-562,271-
treated dHL-60 cells and PF-572,228-treated dHL-60 cells plated on FG.  Scale bar = 
10μm. 
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Figure 2.10.  (A) An image from time-lapse micropipette migration assay of Y-27632-
treated dHL-60 cells (30 μM) and GFP-Pyk2-K457A-transfected dHL-60 cells on FG.  (B) 
ImageJ analysis of overall phospho-myosin pixel intensity of paraformaldehyde-fixed, 
fMLP-stimulated dHL-60 cells, Y-27632-treated dHL-60 cells, and Pyk2-shRNA-
expressing cells plated on FG.  Scale bar = 10μm. 
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Figure 2.11.  (A) Cell velociy measured inμm/min of dHL-60 cells, pSicoR control cells, 
Pyk2-shRNA-expressing cells, and p190RhoGEF-shRNA-expressing cells in 
micropipette migration assay plated on FG.  (B) Stretch index as measured by cell length 
divided by cell width of dHL-60 cells, pSicoR control cells, Pyk2-shRNA-expressing cells, 
and p190RhoGEF-shRNA-expressing cells in micropipette migration assay plated on 
FG.  (C) Number of membrane protrusion exhibited by dHL-60 cells, pSicoR control 
cells, Pyk2-shRNA-expressing cells, and p190RhoGEF-shRNA-expressing cells in 
micropipette migration assay plated on FG. 
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Figure 2.12. 
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Figure 2.12 (continued).  (A) Images from time-lapse micropipette migration assay of 
pSicoR control cells and Pyk2-shRNA-expressing cells plated on FN.  (B) 
Immunostaining of paraformaldehyde-fixed, fMLP-stimulated dHL-60 cells, 
Y-27632-treated dHL-60 cells, and Pyk2-shRNA-expressing cells plated on FG and FN, 
probed for phospho-myosin II and stained with phalloidin. 
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Chapter # 3:  Mammalian Target of Rapamycin and Rictor Control Neutrophil 
Chemotaxis by Regulating Rac/Cdc42 Activity and the Actin Cytoskeleton 
(Data presented in this chapter are published in Journal of Cell Science, 2013, 
http://www.ncbi.nlm.nih.gov/pubmed/24006489) 
 
3.1.  Summary 
Chemotaxis allows neutrophils to seek out sites of infection and inflammation.  
The asymmetric accumulation of filamentous actin (F-actin) at the leading edge provides 
the driving force for protrusion and is essential for the development and maintenance of 
neutrophil polarity.  The mechanism that governs actin cytoskeleton dynamics and 
assembly in neutrophils has been extensively explored and is still not fully understood.  
By using neutrophil-like HL-60 cells, we describe a pivotal role for Rictor, a component 
of Mammalian Target of Rapamycin Complex 2 (mTORC2), in regulating assembly of 
the actin cytoskeleton during neutrophil chemotaxis.  Depletion of Mammalian Target of 
Rapamycin (mTOR) and Rictor, but not Raptor, impairs actin polymerization, leading 
edge establishment and directional migration in neutrophils stimulated with 
chemoattractants.  Intriguingly, depletion of mSin1, an integral component of mTORC2, 
causes no detectable defects in neutrophil polarity and chemotaxis.  In addition, 
experiments with chemical inhibition and kinase-dead mutants indicate that mTOR 
kinase activity and AKT phosphorylation are dispensable for chemotaxis.  Instead, our 
results suggest that the small Rho GTPases Rac and Cdc42 serve as the downstream 
effectors of Rictor to regulate actin assembly and organization in neutrophils.  Together, 
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our findings reveal an mTORC2- and mTOR kinase -independent function and 
mechanism of Rictor in the regulation of neutrophil chemotaxis. 
 
3.2.  Introduction 
Chemotaxis – the ability of cells to migrate up a gradient of chemoattractant – is 
essential for many biological responses, including the movement of neutrophils to the 
sites of infection and inflammation and aggregation of Dictyostelium discoideum (D. 
discoideum) during morphogenesis.  As nature’s master migratory cells, neutrophils and 
D. discoideum respond to chemoattractants by adopting a highly polarized morphology, 
with filamentous actin (F-actin) in a protrusive leading edge.  To interpret the 
chemoattractant gradient, a neutrophil requires a mechanism of comparing signaling 
levels across the cell surface and restricting leading-edge activity to the most highly 
stimulated region.  This mechanism has been referred to as the “compass” mechanism 
because of its ability to spatially direct actin polymerization to the leading edge 
(pseudopod) of protruding neutrophils (Rickert et al., 2000; Bourne and Weiner, 2002; 
Weiner, 2002; Wang, 2009).  Studies carried out over the past decade have begun to shed 
light on the intracellular signals that control assembly of the actin cytoskeleton and the 
establishment of the protruding leading edge, and a special role was assigned to the 
phosphatidylinositol 3-kinase (PI3K) lipid product - PI(3,4,5)P3 in regulating chemotaxis 
of neutrophils and D. discoideum.  Asymmetric localization of PI(3,4,5)P3 at the leading 
edge was first documented in D. discoideum and later in neutrophils during chemotaxis 
(Parent et al., 1998; Meili et al., 1999; Servant et al., 2000; Wang et al., 2002).  
Experiments with pi3k1/2-null D. discoideum and neutrophils with pharmacological 
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inhibition suggested that PI(3,4,5)P3 is required for morphological polarity and 
chemotaxis (Knall et al., 1997; Funamoto et al., 2001; Wang et al., 2002) .  
Although PI(3,4,5)P3 has been suggested as part of the compass mechanism in 
neutrophils and D. discoideum during chemotaxis, it is also clear that cells still can move 
towards chemoattractants regardless of whether this second messenger is depleted or in 
excess (Hirsch et al., 2000; Li et al., 2000; Sasaki et al., 2000; Andrew and Insall, 2007; 
Ferguson et al., 2007; Franca-Koh et al., 2007; Hoeller and Kay, 2007; Nishio et al., 
2007).  Moreover, a recent study suggested that PI3K accelerates, but is not required for, 
neutrophil chemotaxis (Heit et al., 2008).  Thus, cells may use parallel or completely 
independent pathways to direct chemotaxis. Indeed, in D. discoideum, deletion of a 
patatin-like phospholipase A2 (PLA2) homolog and two PI3Ks causes a strong defect in 
chemotaxis and a reduction in receptor-mediated actin polymerization, suggesting that 
PLA2 acts in parallel with PI3K pathways to mediate chemotaxis (Chen et al., 2007).  As 
such, neutrophils may exploit similar PI3K-independent pathway(s) to control leading 
edge establishment and directional migration.  The key mediators of these pathway(s) in 
neutrophils, however, are not known. 
TOR Complex 2 (TORC2) has emerged as a key regulator of the actin 
cytoskeleton. In budding yeast, TORC2 is resistant to rapamycin treatment and regulates 
bud formation (Loewith et al., 2002).  Recently, the homolog of yeast Torc2, mTORC2, 
was identified in mammals.  Depletion of Rictor - a key component of mTORC2 - in 
HeLa cells and fibroblasts disrupts stress fiber formation and reduces Rac activity 
(Jacinto et al., 2004; Sarbassov et al., 2004; Agarwal et al., 2013).  In D. discoideum, 
disruption of TORC2 does not affect cell survival, but impairs cAMP-induced actin 
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polymerization and chemotaxis.  At a molecular level, TORC2 acts downstream of Ras 
and regulates phosphorylation of AKT/protein kinase B (PKB) in a PI(3,4,5)P-
independent manner (Lee et al., 2005; Cai et al., 2010).  More recently, Liu et al used the 
PLB-985 promyeloid leukemia cells as a neutrophil model and showed that Rictor is 
required for chemotaxis (Liu et al., 2010).  Surprisingly, Rictor depletion only impairs 
actin polymerization at the late stage of chemoattractant stimulation, but instead exerts 
much stronger impact on the RhoA-ROCK-myosin pathway (Liu et al., 2010).  In our 
study, we used the commonly used neutrophil-like HL-60 cells and demonstrate that 
mTOR and Rictor are necessary for chemoattractant-induced Rac/Cdc42 activity and 
actin assembly during chemotaxis.  Intriguingly, depletion of mSin1, an integral 
component of mTORC2 (Frias et al., 2006; Jacinto et al., 2006; Yang et al., 2006), 
causes no detectable defects in neutrophil polarity and chemotaxis.  Also, mTOR kinase 
activity and AKT phosphorylation are dispensable for neutrophil chemotaxis.  Together, 
our results suggest that Rictor regulates neutrophil polarity and chemotaxis through an 
mTORC2- and mTOR kinase - independent mechanism(s). 
 
3.3.  Materials and Methods 
Reagents and plasmids 
Human fibrinogen, human serum albumin (HSA) and fMLP were from Sigma-
Aldrich. Rapamycin, Y-27632 and AKTi-1/2 were from Calbiochem.  Torin1 was kindly 
provided by Drs. Nathanael S. Gray (Dana-Farber Cancer Institute, Harvard) and David 
M. Sabatini (Whitehead Institute, MIT).  Rabbit anti-Rictor antibody, Rabbit anti-mSin 1 
antibody and Rictor blocking peptide were from Bethyl laboratories (Montgometry, TX). 
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Rabbit anti-mTOR antibody, rabbit anti-Raptor antibody, rabbit anti-Akt antibody, mouse 
anti-phospho [Thr389]-S6K1, mouse anti-phospho [Ser473] and rabbit anti-phospho 
[Thr308]-Akt antibodies were from Cell Signaling Technology.  Rabbit anti-RhoGDI2 
was from Spring Bioscience.  Alexa fluor 488 phalloidin, alexa fluor 647 phalloidin and 
alexa fluor 594 conjugated secondary antibodies were from Invitrogen.  Goat anti-
GAPDH polyclonal antibody and mouse anti-α-tubulin monoclonal antibody were from 
GenScript and Abcam, respectively.  All secondary antibodies for Western blotting were 
from Jackson ImmunoResearch Laboratories.  Other reagents if not mentioned 
specifically were from Sigma. 
Three shRNA constructs targeting human mTOR [TRCN0000039783, 
TRCN0000039784 and TRCN0000039785; denoted as mTOR shRNA1, shRNA2 and 
shRNA3) and two shRNA constructs targeting human mSin1 (TRCN0000003152 and 
TRCN0000003153; denoted as mSin1 shRNA1 and shRNA2) were from Sigma.  Two 
shRNA constructs targeting human Raptor (Id # 1857 and #1858; denoted as Raptor 
shRNA1 and shRNA2) or Rictor (Id # 1853 and #1854; denoted as Rictor shRNA1 and 
shRNA2) were obtained from Addgene.  The shRNA construct targeting the 3‘-UTR 
region of human Rictor (TRCN0000074288) was from Sigma. pCDNA3 vectors 
containing wild-type mTOR and the kinase-dead mutant are as previously described 
(Vilella-Bach et al., 1999).  The myc-tagged full-length Rictor was from Addgene. 
 
Cell culture, lentiviral infection and primary neutrophil isolation 
Cultivation and differentiation of HL-60 cells and PLB-985 cells were described 
previously (Wang et al., 2002).  Cells were used for experiments on day 6 after DMSO 
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treatment, when minimal cell death was observed (<1%).  For lentiviral production, 
shRNA-containing plasmids were co-transfected with three packaging plasmids pPL1, 
pPL2 and pPL/VSVG (Invitrogen) into HEK293T cells.  After 3 days of transfection, 
supernatant containing the lentiviral particles was concentrated by using Lenti-X 
concentrator (Clontech), added to HL-60 or PLB-985 cells in the presence of 6 μg/ml 
polybrene and incubated with cells for 18-24 hours.  Infected cells were transferred to 
fresh culture medium containing 1.3% DMSO and 0.25 µg/ml puromycin and 
differentiated for 5 days. 
Primary neutrophils were isolated from venous blood from healthy human donors 
as described earlier (Shin et al., 2010). 
 
Immunofluorescence and live-cell imaging 
Procedures for actin staining and immunofluorescence have been described (Shin 
et al., 2010; He et al., 2011).  For live-cell imaging, cells were plated on human 
fibrinogen-coated surface for 20 min, washed briefly, and subsequently stimulated with a 
point source of 10 µM fMLP from a micropipette (Shin et al., 2010; He et al., 2011) or in 
a microfluidic gradient device with cells attached on the bottom of the entire chamber  as 
described (He et al., 2011).  
 
Apoptosis assay 
Apoptosis was measured using the Annexin-V-FITC Apoptosis Detection Kit 
(BD Biosciences), as described (Zhou et al., 2009).  Briefly, cells were washed with cold 
PBS and then resuspended in binding buffer. 5 μl of Annexin-V-FITC and propidium 
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iodide (PI) were added to and incubated with cells for 20 min at RT, which were 
subsequently analyzed using FACSDiva (BD Biosciences).  Cells that are Annexin-V-
positive and PI-negative were counted as apoptotic cells. 
 
Calcium flux 
The procedure for measuring the intracellular calcium release after fMLP 
stimulation was performed as reported previously (Colvin et al., 2006). dHL-60 cells (5 x 
106) were suspended in 1 ml of RPMI medium with 1% BSA.  Cells were incubated with 
Fura-2 AM (5 µM) at 37°C for 20 min.  The cells were washed twice with PBS and 
suspended in 1 ml of calcium flux buffer (145 mM NaCl, 4 mM KCl, 1 mM NaHPO4, 1.8 
mM CaCl2, 25 mM HEPES, 0.8 mM MgCl2, and 22 mM glucose).  Fluorescence readings 
were recorded at 37°C in a fluorimeter ( Molecular Device M5) before and after the 
addition of fMLP.  Intracellular calcium concentrations were presented as the relative 
ratio of excitation fluorescence intensity emitted at 510 nm in response to sequential 
excitation at 340 nm and 380 nm. 
 
Actin polymerization assay 
The procedure for measuring polymerized actin was performed as described 
previously with some modifications (Weiner et al., 2006).  Briefly, 1×106 cells were 
starved in serum-free medium for 1 hour at 37°C and suspended in mHBSS buffer.  Cells 
were stimulated with 100 nM fMLP for indicated times.  After stimulation, cells were 
fixed by adding equal volume of 7.4% paraformaldehyde for 30 minutes at room 
temperature.  Fixed cells were permeabilized and stained in PBS buffer containing 0.1% 
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Triton X-100 and Alexa 488 or 647-conjugated phalloidin (1:100) for 30 minutes at 37°C 
in dark.  Stained cells were washed once and suspended in ice-cold PBS, and 
fluorescence was immediately determined by flow cytometry with a BD Biosciences LSR 
II System.  The mean fluorescence intensity of the cell population was determined. 
Differentiated PLB cells were stimulated with two concentrations of fMLP (100 nM and 
1αM); the latter concentration was used in previous studies (Liu et al., 2010). 
 
Rac/Cdc42 pull-down assay 
Glutathione S-transferase (GST) tagged PAK1-PBD (p21-binding domain of 
PAK1) fusion protein was prepared according to previous report (Benard et al., 1999). 
dHL-60 cells (5 × 106) containing NT shRNA or Rictor shRNAs were starved in serum-
free medium for 1 h at 37°C.  Cells were then suspended in mHBSS buffer and 
stimulated by 100 nM fMLP for various times.  Cell stimulation was stopped by the 
addition of 1.25 × lysis buffer (1× lysis buffer: 25 mM Tris-HCl, pH 7.5, 100 mM NaCl, 
5 mM MgCl2, 1% NP-40, 5% glycerol, 1 mM phenylmethylsulfonyl fluoride, 1 mM 
Diisopropyl phosphorofluoridate and a cocktail of protease inhibitors).  Cell lysates were 
immediately placed on ice.  For adhesion condition, cells were plated on fibrinogen (100 
µg/ml)-coated 6-well plates for 30 min, stimulated with 100 nM fMLP and then lysed.  
The subsequent steps were performed as previous description (Benard et al., 1999).  
Western blotting of Rac, Cdc42 and other proteins were conducted as described 
previously (Xu et al., 2003; Van Keymeulen et al., 2006; Shin et al., 2010; He et al., 
2011).  For Rac pull-down, the levels of both Rac1- and Rac2-GTP were determined. 
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RhoA activation assay 
An absorbance-based RhoA G-LISA kit (Cytoskeleton, Inc) was used to 
determine RhoA-GTP levels in dHL-60. Cells with or without Rictor depletion were 
suspended in mHBSS (5 × 106 cells in 90 μl per condition), and stimulated or 
unstimulated with 10 μl of 1 μM fMLP.  The reaction was stopped by adding 100 μL of 2 
× lysis buffer (provided with the kit) at 4°C.  For adhesion condition, cells were plated on 
fibrinogen (100 µg/ml) coated 6-well plates for 30 min and then stimulated with 100 nM 
fMLP for various times. Subsequent steps were performed as described earlier (He et al., 
2011).  
 
Statistical analysis 
Student’s t-test was used to compare two experimental groups, assuming unequal 
variances.  Differences are considered significant when p < 0.05. 
 
3.4.  Results 
Rictor accumulates at the leading edge of chemotactic neutrophils 
Accumulating evidence has pointed to mTORC2 as an essential regulator of the 
actin cytoskeleton, leading us to examine its function in neutrophils during polarization 
and chemotaxis.  We used neutrophil-like differentiated HL-60 (dHL-60) cells, which 
recapitulate the chemotactic responses of primary blood neutrophils.  Unlike primary 
neutrophils that are short-lived in culture and refractory to genetic manipulations, HL-60 
cells can be continuously cultured and are genetically tractable and therefore have been 
widely used for the study of neutrophil chemotaxis (Servant et al., 2000; Hauert et al., 
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2002; Srinivasan et al., 2003; Xu et al., 2003; Gomez-Mouton et al., 2004; Bodin and 
Welch, 2005; Schymeinsky et al., 2006; Weiner et al., 2006; Nuzzi et al., 2007; Neel et 
al., 2009).  
We assessed the expression of mTOR, Rictor and Raptor in neutrophils.  
Undifferentiated HL-60 cells (uHL-60), dHL-60 and primary human neutrophils 
expressed mTOR, Raptor and Rictor (Figure 3.7A).  Raptor is the major component of 
the mTORC1 (Wullschleger et al., 2006; Bhaskar and Hay, 2007).  Immunofluorescence 
of Rictor in non-stimulated dHL-60 cells was diffusely distributed, with some cortical 
localization around the plasma membranes, but was preferentially distributed to the 
leading edge of 71% of cells (out of 126 examined) treated with the bacteria-derived 
chemoattractant formyl-Met-Leu-Phe (fMLP), co-localizing with F-actin (Figure 3.1A 
and data not shown).  The immunofluorescence was specific for Rictor, as verified by 
competition experiments with a blocking peptide (Figure 3.1A; lower panel).  The 
asymmetric accumulation of Rictor was confirmed by a quantitative analysis of the 
fluorescence intensity across the cell, revealing a steep gradient of fluorescence signals 
(86±15% decrease) (Figure 3.1B).  Moreover, the ratio of mean intensity of Rictor 
immunofluorescence between the leading and the trailing edge was 1.89 ± 0.09 (mean ± 
s.e.m) (Figure 3.1C).  By contrast, the ratio for green fluorescence protein (GFP) in 
polarized dHL-60 cells was 1.12±0.11 (Figure 3.1C), indicating that the asymmetric 
distribution of Rictor was not due to overall morphological changes during neutrophil 
polarization.  
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mTOR and Rictor, but not mSin1, are required for neutrophil polarization and 
chemotaxis 
Rictor’s subcellular localization in polarized neutrophils suggested a potential role 
in controlling leading edge protrusion and chemotaxis.  To test this possibility, we used a 
lentivirus-based system to stably express small hairpin RNAs (shRNAs) that efficiently 
depleted mTOR, Rictor and Raptor in dHL-60 cells (Figure 3.2, A-B).  To ensure 
specificity we used at least two shRNAs that deplete the same target genes.  The 
chemotactic behaviors of mTOR, Raptor or Rictor-depleted cells were examined by using 
a microfluidic gradient device, which enabled us to watch populations of cells moving in 
a highly stable gradient over a long distance (Herzmark et al., 2007; He et al., 2011).  In 
this assay, cells containing non-target (NT) shRNA polarized and moved rapidly in a 
concentration gradient of fMLP (1.4 nM/μm) (Figure 3.2, C-D; Figure 3.7B), as 
described earlier (He et al., 2011).  Interestingly, depletion of Raptor, or treatment with 
rapamycin, a potent and specific inhibitor for mTORC1, caused little effects on cell 
polarization and migration, suggesting that mTORC1 is dispensable for neutrophil 
chemotaxis (Figure 3.2C; Figure 3.7B).  By contrast, cells with mTOR or Rictor 
depletion exhibited severe chemotactic defects (Figure 3.2, C-D; Figure 3.7B).  These 
cells failed to polarize properly and instead formed small, poorly-developed and unstable 
leading edges (Figure 3.2, C-D; Figure 3.7B).  Only 9% of Rictor-depleted cells exhibited 
stable and persistent polarity during migration, in sharp contrast to control cells (89%). 
Furthermore, Rictor-depleted cells migrated much more slowly (Figure 3.2, C-D; Figure 
3.7B), resulting in a large fraction of cells in the lower end of the fMLP gradient (Figure 
3.2C).  In addition, the chemotactic indices, defined as the ratio of migration in the 
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correct direction to the actual length of the migration path (Xu et al., 2005; He et al., 
2011), were 0.81 and 0.63 for control and Rictor-depleted cells, respectively, suggesting 
defects in directional migration upon Rictor depletion (data not shown).  The chemotactic 
behaviors of mTOR and Rictor-depleted cells were also examined by using the 
micropipette chemotaxis assay.  In this assay, mTOR or Rictor-depleted cells showed 
polarization and migration defects highly reminiscent of those in the microfluidic assay 
(Figure 3.7C).  To further examine the specificity of Rictor depletion, we ectopically 
expressed wild-type Rictor in dHL-60 cells with Rictor depleted (Figure 3.2E).  We used 
shRNAs targeting 3’-untranslated region (UTR) of Rictor, which specifically deplete 
endogenous Rictor, not the ectopic form.  The endogenous gene products were depleted 
while the exogenously expressed mRNAs devoid of the 3’-UTR were resistant.  The 
ectopic expression of wild-type Rictor largely rescued the polarization and migratory 
defects caused by Rictor depletion (Figure 3.2, F-G and data not shown).  Taken together, 
these results suggest that mTOR and Rictor, but not Raptor, are required for neutrophil 
chemotaxis.  
mTOR has a well documented role in the regulation of cell growth, survival and 
differentiation (Sarbassov et al., 2005a; Wullschleger et al., 2006; Bhaskar and Hay, 
2007).  We asked whether the migratory defect in cells with mTOR or Rictor depletion 
might be attributed to compromised cell survival and differentiation.  We found that 
Rictor-depleted cells exhibited a similar rate of apoptosis (3.0±1.4%) to the control cells 
(1.8±0.7%), while mTOR depletion slightly increased apoptosis (6.0±2.4%) (Figure 
3.7D).  In addition, Rictor depletion did not alter the level of β2 integrin, a marker for 
neutrophil differentiation (Figure 3.7E).  Interestingly, mTOR depletion significantly 
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reduced the level of β2-integrin (Figure 3.7E).  Furthermore, when exposed to fMLP, 
cells with Rictor depletion showed similar levels of intracellular calcium release to the 
control cells (Figure 3.7F).  Finally, Rictor depletion did not alter fMLP-induced 
phosphorylation of AKT (at threonine 308) (see the rest of this study; Figure 3.8A), again 
demonstrating that Rictor depletion does not non-specifically perturb the function of 
neutrophils.  The differential effect of mTOR depletion on β2 integrin expression is 
probably mediated by mTORC2/Rictor-independent signals and/or other mechanisms.  
To further test the potential role of mTORC2 in controlling leading edge 
protrusion and chemotaxis, we depleted mSin1, an indispensable component of mTORC2 
necessary for AKT phosphorylation at serine 473 (S473) (Frias et al., 2006; Jacinto et al., 
2006; Yang et al., 2006), using two separate shRNAs (Figure 3.8B).  Surprisingly, while 
the shRNAs substantially reduced the levels of mSin1 in dHL-60 cells (Figure 3.8B), we 
failed to detect chemotactic defects in mSin1-depleted cells: these cells migrated with 
similar degree of polarization (81% and 82% of polarized cells for mSin1 shRNA1 and 
shRNA 2, respectively) and migration speeds (3.4 and 3.0 µm/min for shRNA1 and 
shRNA2, respectively) comparable to cells with NT shRNAs (89% and 2.8 µm/min, 
respectively) (Figure 3.8C and data not shown).  Furthermore, mSin1 depletion robustly 
decreased the level of S473-phosphorylated AKT (pS473-AKT) in cells stimulated with 
fMLP (Figure 3.8D), indicating that the depletion effectively impairs downstream 
signaling activities.  Because Rictor, but not mSin1, is required for neutrophil polarity 
and migration, our findings suggest that Rictor regulates neutrophil chemotaxis in an 
mTORC2-independent manner. 
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mTORC2-mediated AKT phosphorylation is not required for neutrophils 
chemotaxis 
The kinase activity of mTOR is responsible for S473 phosphorylation of AKT in 
cells exposed to nutrient signals (Sarbassov et al., 2005b).  In budding yeast, TorC2 
regulates actin polymerization through the ACG kinase YPK2, the yeast AKT homolog 
(Schmidt et al., 1996; Kamada et al., 2005).  Similarly, TORC2 in D. discoideum 
activates PKBR1 and PKBA, the AKT homologues in D. discoideum, which in turn 
regulate polarity and chemotaxis (Lee et al., 2005; Kamimura et al., 2008).  These results 
led us to examine whether AKT might mediate Rictor's response in neutrophils during 
chemotaxis. 
We first assessed the level of S473-phosphorylated AKT in control and Rictor-
depleted cells.  Exposure of control dHL-60 cells to fMLP induced rapid and robust 
phosphorylation of AKT, reaching a maximum at 60 seconds (Figure 3.93, A-B), in 
keeping with earlier reports (Wang et al., 2002; He et al., 2011).  Rictor depletion 
markedly reduced S473-phosphorylation of AKT (to 12.4 % ± 8.2% of control cells) 
(Figure 3.9, C-D).  In contrast, theorine 308 (T308) phosphorylation of AKT, which was 
reportedly catalyzed by PDK1 (Alessi et al., 1997; Belham et al., 1999), was unaltered in 
Rictor-depleted cells (Figure 3.8A).  These data suggested that Rictor is a key regulator 
of AKT S473 phosphorylation in dHL-60 cells exposed to fMLP.  
We next asked whether inhibition of AKT phosphorylation impaired chemotaxis.  
We used a specific AKT inhibitor AKTi-1/2, which abolishes AKT phosphorylation at 
both S473 and T308 in vitro and in vivo (Barnett et al., 2005).  This inhibitor potently 
inhibited AKT phosphorylation in dHL-60 cells and human primary neutrophils (Figure 
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3.9E), but failed to affect chemotaxis in experiments with both the microfluidic (Figure 
3.9, F-G) and the micropipette assays (data not shown).  The AKTi-1/2-treated cells 
polarized and migrated similarly to control cells and exhibit similar chemotactic index 
(0.87 and 0.86, respectively) (Figure 3.9, F-G, and data not shown).  These data indicate 
that AKT phosphorylation is not responsible for Rictor's function in neutrophil 
polarization and chemotaxis.  
 
mTOR kinase activity is dispensable for chemotaxis  
The lack of function for AKT phosphorylation in chemotaxis led us to ask 
whether mTOR kinase activity was required for neutrophil polarization and chemotaxis.  
Recently, an ATP analogue inhibitor of mTOR kinase, Torin1, was developed and 
reportedly inhibits mTORC1 and mTORC2 kinase activities in a variety of cells (Thoreen 
et al., 2009).  We assessed the effect of Torin1 on neutrophil chemotaxis.  
We found that Torin1 treatment markedly reduced the levels of both 
phosphorylated S6K1 (at threonine 389) and AKT (by 84% and 88%, respectively) 
(Figure 3.3A; Figure 3.10, A-B).  By contrast, rapamycin treatment reduced S6K1 
phosphorylation by 79% but had little effect on AKT phosphorylation (Figure 3.3A; 
Figure 3.10, A-B).  Despite its ability to inhibit S6K1 and AKT phosphorylation, Torin1 
treatment had no detectable effects on chemotaxis of dHL-60 cells and primary 
neutrophils (Figure 3.3, B-C, Table 1 and data not shown).  
To further determine whether the kinase activity of mTOR was required for 
chemotaxis, we ectopically expressed wild-type mTOR and the kinase-dead mutant 
(Asp2357-Glu) (Vilella-Bach et al., 1999) in dHL-60 cells with endogenous mTOR 
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depleted (Figure 3.3D).  As shown in Figure 3.3E and 3.3F, expression of either wild-
type mTOR or the kinase-dead mTOR mutant largely rescued the chemotactic defects 
caused by mTOR depletion.  To specifically deplete endogenous mTOR, not the ectopic 
form, we used shRNAs targeting 3’- UTR of mTOR.  Together, these data indicate that 
mTOR kinase activity is dispensable for neutrophil chemotaxis. 
 
mTOR and Rictor regulate assembly of the actin cytoskeleton in neutrophils  
How might Rictor control neutrophil polarization and chemotaxis?  The emerging 
role of TORC2/Rictor in regulating the actin cytoskeleton in several cell types (Schmidt 
et al., 1996; Jacinto et al., 2004; Sarbassov et al., 2004; Wullschleger et al., 2006), 
asymmetric localization of Rictor at the leading edge of neutrophils (Figure 3.1) and the 
effect of Rictor depletion on neutrophil leading edge establishment and polarization 
(Figure 3.2) led us to ask whether Rictor regulates fMLP-induced actin skeleton assembly 
in neutrophils during chemotaxis.   
We measured the level of F-actin in both suspended and adherent cells with or 
without Rictor depletion (Figure 3.4).  As described previously (Wang et al., 2002; 
Weiner et al., 2006; Shin et al., 2010), exposure of suspended control dHL-60 cells (i.e., 
containing NT shRNAs) induced rapid and transient actin polymerization, which peaked 
at around 1 min (Figure 3.4A).  Rictor depletion moderately reduced the level of F-actin 
in cells under resting conditions (by ~20%) and substantially abolished the transient 
accumulation of F-actin in suspended cells after exposed to chemoattractant (Figure 
3.4A).  Similarly, mTOR depletion also substantially decreased the level of actin 
polymerization in suspended dHL-60 cells (Figure 3.11A).  In addition, when plated on 
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the fibrinogen substrate and exposed to a uniform concentration of fMLP, control cells 
developed a polarized morphology with F-actin concentrated at the leading edge, as 
revealed by phalloidin staining (Figure 3.4B, top panel).  Rictor depletion in the adherent 
cells nearly completely prevented the polarized morphology and F-actin accumulation 
(Figure 3.4B).  A quantitative analysis revealed that only 12% of Rictor-depleted cells 
showed asymmetric accumulation of F-actin at the leading edge, in sharp contrast to 
controls cells (78%) (Figure 3.4C).  Similar to Rictor depletion, mTOR depletion 
markedly impaired F-actin accumulation in adherent cells, in keeping with its effect on 
cell polarization and migration (Figure 3.4B).  
To document the response of actin throughout fMLP stimulation, we assessed the 
effect of Rictor depletion in live cells.  We delivered NT shRNA or Rictor-specific 
shRNAs into dHL-60 cells  stably expressing actin-YFP (Shin et al., 2010) and 
stimulated the cells with a point source of fMLP.  As shown earlier (Shin et al., 2010), 
control cells responded to fMLP stimulation by translocating actin-YFP from the cytosol 
to the cell's leading edge (Figure 3.4D).  By contrast, in Rictor-depleted cells actin-YFP 
remained diffusely distributed through the entirely course of fMLP stimulation (Figure 
3.4D).  Only 1 out 14 Rictor-depleted cells showed actin accumulation, in contrast to 
control cells (16 out of 18).  
We next asked whether Rictor depletion also influenced the level of F-actin in the 
neutrophil-like PLB-985 cells.  Two shRNAs effectively depleted Rictor in differentiated 
PLB-985 (dPLB-985) cells, consistent with their effects in dHL-60 cells (Fig. S5B).  
Rictor depletion markedly reduced the migration speed of dPLB-985 cells and the level 
of actin polymers in response to fMLP stimulation (Figure 3.11, C-D and data not 
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shown).  These effects were similar to those in dHL-60 cells.  Together, our findings 
suggest that Rictor acts to control assembly of the actin cytoskeleton in neutrophils 
during chemotaxis.  
 
Depletion of Rictor inhibits Rac and Cdc42 activities 
If AKT does not mediate Rictor's function in neutrophils, how might Rictor 
regulate actin polymerization and organization during neutrophil chemotaxis?  Rac and 
Cdc42 are members of the Rho GTPase family that have well established roles in the 
regulation of actin dynamics in various cell types (Sanchez-Madrid and del Pozo, 1999; 
Etienne-Manneville and Hall, 2002).  Rac2 deletion in mouse neutrophils or expression 
of dominant negative Rac mutants in human neutrophil cell lines markedly prevents cell 
polarization and actin polymerization (Roberts et al., 1999; Williams et al., 2000; 
Srinivasan et al., 2003).  Inhibition of Cdc42 in neutrophils with dominant negative 
mutants impairs leading edge stability and persistent motility (Srinivasan et al., 2003).  
We therefore asked whether Rac and/or Cdc42 might serve as downstream targets to 
mediate the function of Rictor in neutrophils (Figure 3.5).  
We first assessed the level of Rac-GTP using a previously described pull-down 
method (Benard et al., 1999) in suspended dHL-60 cells.  When in suspension, cells are 
free of other signaling input and provide a better understanding of chemoattractant-
induced signaling activities.  Under these conditions, the level of Rac-GTP increased 
rapidly and transiently after exposure to fMLP, reaching a maximum at 30 sec (Figure 
3.5A), in keeping with earlier reports (Benard et al., 1999; Xu et al., 2003; Van 
Keymeulen et al., 2006).  Rictor depletion reduced the level of Rac-GTP by more than 
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60% (37.6% ± 3.7% of control) (Figure 3.5, A-B).  The inhibitory effect of Rictor 
depletion on Rac activity was also observed in cells adhered to the fibrinogen-coated 
substrate (Figure 3.5, C-D).  Notably, in adherent cells Rictor depletion reduced the level 
of active Rac not only in cells stimulated with fMLP, but also in those without fMLP 
stimulation (Figure 3.5, C-D).  Furthermore, Rictor depletion substantially reduced the 
activity of Cdc42 in dHL-60 cells (Figure 3.5, E-F).  Similar to Rictor depletion, 
depletion of mTOR also decreased the levels of active Rac and Cdc42 in fMLP-
stimulated cells (Figure 3.12).  Therefore, Rac and Cdc42 might function as key effectors 
of Rictor to mediate actin polymerization and organization in neutrophils during 
chemotaxis.  The relative high level of Rac activity in adherent cells prior to fMLP 
stimulation probably resulted from cell adhesion to the ECM substrate; it is well known 
that integrin-ECM ligation can induce Rac activation (Price et al., 1998). 
Recently, Liu et al reported that in differentiated PLB-985 cells mTORC2 
primarily controls myosin II activity through a cAMP/RhoA-signaling axis (Liu et al., 
2010).  These findings prompted us to evaluate whether Rictor depletion in dHL-60 cells 
also affected Rho activities.  In suspended cells, Rictor depletion in dHL-60 cells led to 
increased Rho activation, only after prolonged fMLP stimulation (Figure 3.13A).  
However, in adherent cells no significant difference in RhoA activity was observed 
between control and Rictor-depleted cells (Figure 3.13B).  These results suggest that the 
RhoA signaling pathway is probably not the main target of Rictor in dHL-60 cells.  
Rho-GDP dissociation inhibitor (RhoGDI) is known to function as an inhibitor of 
the Rho family proteins.  It was recently reported that Rictor regulates migration of 
mouse embryonic fibroblasts by suppressing the level of RhoGDI2 (Agarwal et al., 
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2013).  Depletion of Rictor in these cells thereby leads to increased RhoGDI2 levels, 
which consequently decreases the activity of Rac and Cdc42.  To investigate whether 
Rictor also modulates RhoGDI2 in dHL-60 cells, we assessed the protein level of 
RhoGDI in Rictor-depleted cells.  We did not observe alterations in RhoGDI2 protein 
levels upon Rictor depletion (Figure 3.13C).  Thus, RhoGDI2 is unlikely involved in 
Rictor regulation of Rac and Cdc42 activities in neutrophils. 
 
Actin polymers are not responsible for Rictor regulation of Rac activity 
It was previously demonstrated that actin polymers serve as a component of a 
feedback loop containing PI(3,4,5)P3  and Rac (Xu et al., 2003) in chemotaxing 
neutrophils and that inhibition of actin polymerization impairs chemoattractant-induced 
Rac activation (Van Keymeulen et al., 2006).  Because Rictor depletion markedly 
reduced the level of actin polymers (Figure 3.4A), these findings raise the possibility that 
Rictor might regulate Rac activity via actin polymerization.  To test this, we treated dHL-
60 cells with latrunculin B, a widely used inhibitor of actin polymerization, and assessed 
the effect on fMLP-induced Rac activation (Figure 3.6, A-C).  As shown in Figure 3.6B 
and 3.6C, treatment of cells with an intermediate concentration of latrunculin B (10 
µg/ml, 10 min pretreatment) slightly reduced fMLP-induced Rac activation (~9% 
reduction compared with control cells), while a higher latrunculin B concentration (20 
µg/ml) caused a stronger effect (~26% reduction).  Notably, even at the concentration of 
10 µg/ml, latrunculin B had a stronger inhibitory effect on actin polymerization than 
Rictor depletion (Figure 3.6A; compare with Figure 3.4A).  Because Rictor depletion led 
to more than 60% reduction in Rac-GTP (Figure 3.5, A and B), the decrease in actin 
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polymerization alone cannot account for Rictor's effect on Rac activities.  Therefore, 
actin polymerization might contribute to but is not responsible for Rictor regulation of 
Rac activities in neutrophils during chemotaxis. 
In keeping with these results, although dHL-60 cells with latrunculin B 
pretreatment (10 µg/ml, 10 min) failed to polarize and exhibited little actin polymers to 
fMLP stimulation (Figure 3.6, A and D, bottom panel), they nevertheless exhibited 
prominent cortical localization of Rictor around the cell’s periphery (Figure 3.6D).  In 54 
cells examined, 39 cells (72%) exhibited accumulation of Rictor immunofluorescence in 
the cortical areas of fMLP-stimulated cells.  These findings suggest that Rictor likely acts 
upstream of actin assembly in the chemotactic signaling cascade in neutrophils. 
 
3.5.  Discussion 
In conclusion, our results reveal a critical role for mTOR and Rictor in the 
regulation of neutrophil chemotaxis.  We found that depletion of mTOR and Rictor in 
neutrophil-like dHL-60 cells impairs leading edge establishment, cell polarization and 
directional migration.  Our data suggest that Rictor regulates neutrophil polarity and 
chemotaxis by primarily controlling the actin cytoskeleton assembly and organization at 
the neutrophil's leading edge.  First, in response to chemoattractant, Rictor translocates to 
the leading edge of polarizing neutrophils, co-localizing with F-actin.  Second, depletion 
of Rictor impairs chemoattractant-induced actin polymerization both in suspended and 
adherent cells.  Finally, depletion of Rictor substantially reduces activities of Rac and 
Cdc42, both of which are essential regulators of actin dynamics and neutrophil 
chemotaxis.  Our results confirm and extend previous findings in budding yeast, D. 
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discoideum, 3T3 fibroblasts and HeLa cells, demonstrating that Rictor is an essential 
regulator of the actin cytoskeleton in neutrophils during chemotaxis.  In addition, we 
show, for the first time, that Rictor regulates neutrophil chemotaxis through mechanisms 
independent of mTORC2 and mTOR kinase activity.  
How might mTOR and Rictor regulate the actin cytoskeleton in neutrophils?  
Intriguingly, our experiments show that depletion of mSin1, an integral component of 
mTORC2, causes no detectable defects in neutrophil polarization and migration, 
suggesting that Rictor functions through an mTORC2-independent mechanism(s).  Our 
results are in keeping with a recent report,  which demonstrated that Rictor controls 
migration of mouse embryonic fibroblasts (MEF) in an mSin1-independent manner 
(Agarwal et al., 2013).  However, Agarwal et al did not examine the function of mTOR 
in MEF migration.  An mTORC2-independent function was also reported for Rictor in 
promoting SGK1 ubiquitination and destruction (Gao et al., 2010).  In addition, we found 
that mTOR kinase activity is dispensable for chemotaxis, and in keeping with the lack of 
kinase function, inhibition of AKT activity in neutrophils fails to affect cell polarization 
and chemotaxis, indicating that unlike in D. discoideum, AKTs are not a major effector of 
Rictor in regulating chemotaxis.  Instead, we show that Rictor depletion markedly 
reduces Rac and Cdc42 activities, similar to earlier studies using fibroblasts (Jacinto et 
al., 2004; Agarwal et al., 2013).  Interestingly, although inhibition of mTOR kinase 
activity has little effect, depletion of mTOR significantly impairs neutrophil polarity and 
migration, highly reminiscent of the defects caused by Rictor depletion.  Whether mTOR 
interacts with Rictor to regulate neutrophil chemotaxis or these two molecules function 
independently remains to be defined. 
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Given the established roles of Rac and Cdc42 in the regulation of actin assembly 
and organization in neutrophils, it is likely that Rac and Cdc42, instead of RhoA, are the 
downstream targets that mediate Rictor's function during chemotaxis.  First, the 
difference in RhoA activity between control and Rictor-depleted cells in suspension is 
very minimal at the early stage of fMLP stimulation (30 s) (Figure 3.13A), while the 
decrease in Rac/Cdc42 activity and F-actin is much more significant at this time point.  
Furthermore, Rictor depletion in adherent cells fails to reduce RhoA activity (Figure 
3.13B), but significantly decreases Rac activity throughout fMLP stimulation (Figure 
3.5C-D).  Four possibilities, alone or in combination, could account for the actions of 
Rictor on Rac/Cdc42.  It might be that Rictor carries its mTORC2-independent functions 
by binding to integrin-linked kinase (McDonald et al., 2008), which can regulate 
Rac/Cdc42 activities via the guanine-nucleotide exchange factor (GEF) PIXα as reported 
for mammary epithelial cells (Filipenko et al., 2005).  Also, Rictor could control the 
activity of Rac/Cdc42 via direct interaction and regulation.  Indeed, a recent study 
suggested that mTOR binds directly to Rac1 (Saci et al., 2011), but to date there is no 
report of Rictor interaction with the Rho GTPase.  Alternatively, Rictor might be directly 
involved in the activation of Rac/Cdc42 GEFs such as DOCK2, PIXα and P-Rex1. 
DOCK2 and PIXα are known to regulate Rac/Cdc42 activities in neutrophils (Li et al., 
2003; Kunisaki et al., 2006), while P-Rex1 co-precipitates with Rictor in HeLa cells and 
may link mTORC2/Rictor to activation of Rac signaling (Hernandez-Negrete et al., 
2007).  Finally, Rictor might target negative regulators of Rac/Cdc42 such as GTPase-
activating proteins (GAPs).  Importantly, although Rictor depletion profoundly impairs 
actin polymerization, it is unlikely that Rictor controls Rac activity via actin polymers.  
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This is because an intermediate concentration of latrunculin B exerts a stronger effect on 
actin polymerization than Rictor depletion, but only slightly reduces Rac activity (by 
~10%).  More complete understanding of the detailed mechanisms by which Rictor and 
mTOR regulates Rac/Cdc42 activity and the actin cytoskeleton awaits future 
experiments. 
Notably, although the polarization and migratory defects of Rictor depletion in 
our study are very similar to those reported in an earlier study (Liu et al., 2010), there are 
discrepancies with respect to the effects of Rictor depletion at the molecular level. For 
instance, Liu et al (Liu et al., 2010) showed that Rictor depletion in dPLB-985 cells 
reduces F-actin levels at later time points of fMLP stimulation (> 1 min), with little effect 
at the early stage.  In contrast, we observed significant decreases in F-actin levels 
throughout fMLP stimulation.  The variation cannot be simply attributed to the 
differences in cell types, because we used both dHL-60 and dPLB-985 cells and obtained 
similar results.  Furthermore, while Liu et al reported significant increase in RhoA 
activity upon Rictor depletion with or without fMLP stimulation, the increase in RhoA 
activity upon Rictor depletion in our experiments is limited to suspended cells with 
prolonged fMLP stimulation.  The following factors might contribute to the discrepancies 
between the two studies.  First, clonal differences between the cell lines may result in the 
experimental variations.  In addition, different shRNAs targeting Rictor were used in 
these studies and could lead to differential effects in Rictor depletion as well as Rictor-
mediated signaling pathways.  Furthermore, the promyeloid leukemia cell lines such as 
HL-60 and PLB-985 can give rise to variations when induced to differentiate into 
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neutrophil-like cells and/or manipulated genetically, which may lead to the variations 
between the studies.  
It is well established that Rho GTPases can regulate each other's activity through 
crosstalk during cell polarization and migration (Iden and Collard, 2008).  For instance, 
during migration of slow-moving cells such as fibroblasts, activation of Rac and Cdc42 
signaling antagonizes RhoA activity (Sander et al., 1999).  Interestingly, although 
depletion of Rictor significantly reduces the level of Rac and Cdc42 in dHL-60 cells, the 
down-regulation of Rac and Cdc42 activity exerts little effect on RhoA activity, both at 
early time points after fMLP stimulation in suspended cells and throughout fMLP 
stimulation in adherent cells.  The absence of a clear antagonistic pattern between 
Rac/Cdc42 and RhoA activities can be attributed to the complex interplay between Rho 
GTPase in neutrophils during chemotaxis.  In an earlier study, Van Keymeulen et al (Van 
Keymeulen et al., 2006) showed that pharmacological inhibition of PI3Kγ in neutrophils 
not only prevents fMLP-induced Rac and Cdc42 activation, but also significantly reduces 
RhoA activities.  It was further proposed by Van Keymeulen et al that Cdc42 maintains 
stable polarity by strengthening the leading edge and also, at longer range, by promoting 
RhoA-dependent actomyosin contraction at the trailing edge (Van Keymeulen et al., 
2006).  In a separate study, Pestonjamasp et al (Pestonjamasp et al., 2006) used primary 
human neutrophils and neutrophils derived from a Rac1/Rac2-null transgenic mouse 
model to show that Rac1 is essential for Rho and myosin activation at the trailing edge to 
regulate uropod function.  Thus, Rac and Cdc42 can play both positive and negative roles 
in the regulation of the RhoA-myosin program during chemotaxis. 
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Our findings raise the interesting possibility that Rictor might be involved in the 
compass mechanism that directs actin polymerization at the neutrophil’s leading edge.  In 
this highly putative scenario, upon stimulation of chemoattractant Rictor is recruited to 
the leading edge, where it activates Rac and Cdc42 and consequently induces localized 
actin polymerization.  The asymmetric accumulation of Rictor in polarized neutrophils 
and the profound effects of Rictor depletion on neutrophil polarization and motility 
support this notion.  Notably, Rictor depletion in dHL-60 cells leads to profound defects 
in cell polarization and motility.  By contrast, perturbations that lower PI(3,4,5)P3 
production only have partial effects on chemotaxis in human and mouse neutrophils.  
These results suggest that Rictor likely plays a more significant role in regulating leading 
edge establishment and polarization of neutrophils than PI(3,4,5)P3.  However, at this 
point it is unclear whether Rictor is also essential for chemotaxis of neutrophils in 
response to other chemoattractants such as C5a and IL-8.  It is also unclear whether 
Rictor plays an instructive or permissive role in neutrophil polarization.  As such, future 
experiments should investigate whether localized activation of Rictor is sufficient to 
induce actin polymerization and neutrophil polarization.  An approach that involves the 
use of rapamycin-binding domain of mTOR (FRB), the protein of interest conjugated 
with a FK506-binding protein and the use of small-molecule dimerizers (Inoue et al., 
2005; Bayle et al., 2006; Inoue and Meyer, 2008) can be potentially used to induce 
localized activation of Rictor.  This approach was already applied to the study of 
neutrophil polarity and chemotaxis (Inoue and Meyer, 2008). 
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3.6.  Figures 
 
 
 
Figure 3.1. 
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Figure 3.1 (continued).  Rictor is recruited to the leading edge of polarized dHL-60 
cells.  (A) Immunofluorescence of Rictor (red) and F-actin (green) in cells plated on 
fibrinogen without (top) or with (middle) fMLP stimulation (100 nM, 2 min).  Fluorescence 
images of Rictor (red), F-actin (green), Rictor/F-actin merged images, and differential 
interference contrast (DIC) images of cells.  The Rictor immunofluorescence is specific 
because incubation with the Rictor peptide completely abolishes the 
immunofluorescence (bottom).  Bar, 10 μm.  (B) Fluorescence line profiles of Rictor (red) 
and F-actin (green) in dHL-60 cells with or without fMLP stimulation.  The graph below 
the fluorescence image plots the fluorescence intesntiy of each probe (y-axis) vs. the 
distance (x-axis) for the corresponding cell.  (C) Ratios of mean fluorescence intensity of 
Rictor and GFP between the front and the back of cells.  Left, representative Rictor and 
GFP images; right, quantification of 41 cells (for Rictor) and 38 cells (for GFP) collected 
from four independent experiments.  The front of the cell is defined as the area within the 
first 3 μm of the cell (indicated by the yellow line), as depicted earlier (Shin et al., 2010), 
and the rest of the cell is defined as the back.  Student’s t test was performed.  The 
asterisk indicates that the ratio for Rictor differs statistically from that of GFP (*p < 0.01). 
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Figure 3.2. 
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Figure 3.2 (continued).  Rictor depletion impairs dHL-60 chemotaxis.  (A) Western 
blotting of mTOR, Raptor, and Rictor in dHL-60 cells transfected with specific or NT 
shRNAs.  GAPDH was a loading control.  HL-60 cells were infected with lentiviruses 
containing the various shRNAs and were differentiated for 5 d in the presence of DMSO.  
(B) Relative levels of mTOR, Raptor, and Rictor in cells with or without depletion.  
Values are normalized to the level in control cells (with the NT shRNA, 100%) and are 
means ± SEM (n = 4).  (C) Chemotaxis of dHL-60 cells with various treatments in a 
microfluidic gradient device.  After adhering to the fibrinogen-coated surface of the 
microfluidic chamber, cells (2 × 106) were exposed to an fMLP gradient for 20 min. 
Phase-contrast images of cells 10 and 910 s after fMLP stimulation.  Bar, 50 μm.  (D) 
Images with higher magnification of cells with NT (I) and Rictor shRNA (II) treatment, 
910 s after exposure to fMLP gradients.  Bar, 10 μm.  (E) Western blotting of Rictor in 
control and Rictor-depleted dHL-60 cells with or without rescue. Rictor-depleted cells 
were differentiated and transfected with wild-type (WT) Rictor.  α-Tubulin was a loading 
control.  (F) Wild-type Rictor rescues the migratory defects of Rictor-depleted cells 
revealed with the micropipette assay.  Time-lapse images of representative cells for 
various conditions.  The three images in each column show the positions of individual 
cells (identified with a superimposed letter) after exposure to fMLP. Bar, 10 μm.  (G) 
Speeds of cell migration for control, Rictor-depleted, and rescued cells revealed with the 
micropipette assay.  Values are means ± SEM (n = 21 for control, 16 for Rictor shRNA 
alone, and 15 for Rictor shRNA plus wild-type Rictor).  The cells with Rictor rescue differ 
statistically from the Rictor-depleted cells (p < 0.01). 
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Figure 3.3. 
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Figure 3.3 (continued).  mTOR kinase activity is dispensable for chemotaxis.  (A) 
Western blotting of AKT (p-S473) and S6K1 (p-T389) phosphorylation in cells pretreated 
with vehicle (DMSO), rapamycin (100 nM), or Torin1 (250 nM) for 30 min and stimulated 
with fMLP (100 nM) for indicated time points.  AKT is the loading control.  (B) 
Chemotaxis of dHL-60 cells with or without Torin1 treatment (250 nM, 30 min) in a 
microfluidic gradient device.  Phase-contrast images of cells 10 and 480 s after fMLP 
stimulation.  Bar, 50 μm.  (C) Trajectory of dHL-60 cells migrating in the microfluidic 
chamber.  Cell migration was recorded using time-lapse microscope, and the migration 
path of individual cells was analyzed and plotted using ImageJ (National Institutes of 
Health, Bethesda, MD).  (D) Western blotting of mTOR in control and mTOR-depleted 
dHL-60 cells with or without rescue.  mTOR-depleted cells were differentiated and 
transfected with WT mTOR or a kinase-dead mutant of mTOR.  mTOR was depleted 
with shRNA-3, which targets the 3′-UTR of mTOR and thus exerts no effect on 
ectopically expressed mTOR.  GAPDH is the loading control.  (E) Both wild-type mTOR 
and the kinase-dead mTOR mutant rescue the migratory defects of mTOR-depleted 
cells revealed with the micropipette assay.  Time-lapse images of representative cells for 
various conditions.  The two images in each column show the positions of individual cells 
(identified with a superimposed letter) after exposure to fMLP.  Bar, 10 μm.  (F) Speeds 
of cell migration for control, mTOR-depleted, and rescued cells revealed with the 
micropipette assay.  Values are means ± SEM (n = 18 for control, 19 for mTOR shRNA 
alone, 17 for mTOR shRNA plus wild-type mTOR, and 15 for mTOR shRNA plus mTOR 
kinase-dead mutant).  Asterisks indicate that the cells differ statistically from the mTOR-
depleted cells (*p < 0.001). 
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Figure 3.4. 
 
  
94 
 
 
 
Figure 3.4 (continued).  Rictor depletion impairs actin polymerization in dHL-60 
cells.  (A) Quantification of F-actin levels in suspended cells. Cells with or without Rictor 
depletion were stimulated with fMLP (100 nM) for various times in suspension and fixed 
for staining with fluorescently labeled phalloidin.  Fluorescence in stained cells was 
determined by flow cytometry.  Values are mean ± SEM (n = 4).  (B) F-actin staining of 
dHL-60 cells with or without Rictor or mTOR depletion after fMLP stimulation.  Cells 
were plated on fibrinogen-coated coverslips for 20 min and stimulated with uniform fMLP 
(100 nM) for 2 min. Images of F-actin and DIC.  Bar, 10 μm.  (C) Quantification of the 
number of dHL-60 cells with polarized actin polymerization with and without Rictor 
depletion.  Cells were stimulated with uniform fMLP (100 nM) for 2 min, as described in 
B.  Each bar represents the mean ± SEM (n = 4).  (D) The dynamics of actin-YFP in 
dHL-60 cells exposed to an fMLP gradient. HL-60 cells stably expressing actin-YFP 
were infected with lentivirus containing NT shRNA or Rictor shRNA (shRNA-1) and 
subsequently differentiated for 5 d.  Cells were plated on fibrinogen-coated coverslips 
and stimulated with a chemotactic gradient delivered by a micropipette containing 10 μM 
fMLP for the times indicated.  Fluorescence images of actin-YFP and the corresponding 
DIC images.  Bar, 10 μm. 
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Figure 3.5. 
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Figure 3.5 (continued).  Rictor depletion impairs Rac and Cdc42 activities in dHL-
60 cells.  (A) The levels of Rac-GTP in suspended dHL-60 cells.  dHL-60 cells with or 
without Rictor depletion were stimulated with 100 nM of fMLP for various time points in 
suspension and lysed for the pull-down assay.  Levels of total Rac were used to show 
cell lysate input.  (B) Quantification of relative levels of Rac-GTP level in suspended 
dHL-60 cells with and without Rictor depletion 30 s after fMLP stimulation.  Each bar 
represents the mean ± SEM (error bars).  Values are normalized to the level of Rac-GTP 
(= 100%) in cells without Rictor depletion (*p < 0.001).  (C) The levels of Rac-GTP in 
adherent dHL-60 cells.  Control cells or Rictor-depleted cells plated on fibrinogen-coated 
plates were unstimulated or stimulated for 1 or 5 min with a uniform concentration of 
fMLP (100 nM) and lysed for pull-down assay.  Levels of total Rac were used to show 
cell lysate input.  (D) Quantification of relative levels of Rac-GTP in adherent dHL-60 
cells with and without Rictor depletion.  Each bar represents the mean ± SEM (n = 4).  
Values are normalized to the level of Rac-GTP (= 100%) in cells without Rictor depletion 
before fMLP stimulation (*p < 0.001).  (E) The levels of Cdc42-GTP in dHL-60 cells with 
or without Rictor depletion. dHL-60 cells with or without Rictor depletion were stimulated 
with 100 nM of fMLP for 30 s in suspension and lysed for the pull-down assay.  Levels of 
total Cdc42 were used to show cell lysate input.  (F) Quantification of relative levels of 
Cdc42-GTP in suspended dHL-60 cells with and without Rictor depletion.  Each bar 
represents the mean ± SEM (n = 4).  Values are normalized to the level of Cdc42-GTP 
(= 100%) in cells without Rictor depletion before fMLP stimulation (*p < 0.001). 
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Figure 3.6.  Actin polymers are not responsible for Rictor regulation of Rac 
activity.  (A) Quantification of F-actin levels in suspended cells.  Cells with or without 
pretreatment of latrunculin B (10 μg/ml, 10 min) were stimulated with fMLP (100 nM) for 
various times in suspension and fixed for staining with fluorescently labeled phalloidin.  
(B) The levels of Rac-GTP in suspended dHL-60 cells with or without latrunculin B 
pretreatment (10 min; 10 μg/ml, top; 20 μg/ml, bottom) were stimulated with 100 nM of 
fMLP (30 s) and lysed for the pull-down assay.  Levels of total Rac were used to show 
cell lysate input.  (C) Quantification of relative levels of Rac-GTP level in suspended 
dHL-60 cells with or without latrunculin B pretreatment 30 s after fMLP stimulation.  Each 
bar represents the mean ± SEM (error bars).  Values are normalized to the level of Rac-
GTP (= 100%) in cells without latrunculin B pretreatment (*p < 0.001).  (D) The 
fluorescence image of Rictor (green), F-actin (red), and merged Rictor and F-actin image 
and DIC image of dHL-60 cells pretreated or not pretreated with latrunculin B (10 μg/ml, 
10 min) and stimulated with a uniform concentration of fMLP (100 nM, 1 min).  The white 
arrows point to the areas with Rictor cortical localization.  Bar, 10 μm. 
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Table 3.1.  Effects of drug inhibition on dHL-60 cell and primary neutrophil 
chemotaxis. 
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Figure 3.7. 
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Figure 3.7 (continued).  (A) Western blotting of mTOR, Rictor and Raptor in 
undifferentiated HL-60 cells (uHL-60), differentiated HL-60 cells (dHL-60) and human 
primary neutrophils (1º neutrophil).  GAPDH was a loading control.  (B) Outlines (top) 
and migration speeds (bottom) of cells responding to the fMLP stimulation in the 
microfluidic chamber, as shown in Figure 3.2C.  Each set of outlines represents a single 
cell observed at indicated intervals (denoted by different colors) after exposure to fMLP, 
and two representative cells are shown for each condition.  Values for migration speeds 
are mean ± SEM (n >40).  (C) Cells containing non-target (NT) shRNA, mTOR shRNA-3, 
Rictor shRNA-1 or Raptor shRNA-1 were allowed to migrate toward chemoattractant-
containing micropipette (fMLP, 10 μM) on a fibrinogen-coated substrate.  The two 
images in each row show the positions of individual cells (identified with a superimposed 
letter) after exposure to fMLP. Bar. 10 μm.  (D) Apoptotic assay of control cells or mTOR 
and Rictor depleted cells.  Cells were infected with lenti-viral particles containing NT 
shRNA, mTOR shRNA-3 or Rictor shRNA-1 and differentiated for 5 days.  Cells were 
prepared according to the manufacturer's instructions (FITC Annexin V Apoptosis 
Detection Kit I, BD Pharmingen) and analyzed by flow cytometry.  (E) Flow cytometry 
analysis of surface expression of β2 integrin in control, mTOR- and Rictor-depleted cells 
after fMLP stimulation (100 nM, 10 min).  The black line indicates background 
fluorescence from the isotype control IgG.  (F) Analysis of intracellular [Ca2+] in cells 
containing NT shRNA or Rictor shRNA in response to fMLP stimulation. Fluorescence 
was recorded using SpectraMax M2 spectrometer (excitation: 340-380 nm; emission: 
510 nm).  Results are plotted as emission ratio vs. time. Arrow indicates the time of 
addition of fMLP (100 nM).  A representative experiment from eight separate 
experiments is shown. 
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Figure 3.8.  
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Figure 3.8 (continued).  (A) Western blotting of phosphorylated AKT (p-T308) in 
dHL-60 cells with or without Rictor depletion.  Cells were stimulated with 100 nM fMLP 
for 1 minute or unstimulated.  Total AKT was the loading control for each condition.  The 
Rictor blot is also shown.  (B) Western blotting of mSin1 in dHL-60 with or without the 
treatment of mSin1 shRNAs.  α-tubulin was a loading control.  (C) Cells containing NT 
shRNA, mSin1 shRNA-1 or mSin1 shRNA-2 were allowed to migrate toward 
chemoattractantcontaining micropipette (fMLP, 10 μM) on a fibrinogen-coated substrate. 
The three images in each row show the positions of individual cells after exposure to 
fMLP for indicated times.  Bar, 10 μm.  (D) Top: Western blotting of AKT (p-S473) 
phosphorylation in cells with or without mSin1 depletion.  Cells were stimulated with 
fMLP (100 nM) for 1 min.  Total AKT was a loading control.  Bottom: Quantification of 
relative levels of p-S473 AKT in cells with and without mSin1 depletion.  Each bar 
represents the mean ± SEM (n = 4).  Values are normalized to the level of p-S473 AKT 
(=100%) in cells treated with NT shRNA. 
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Figure 3.9. 
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Figure 3.9 (continued).  (A) dHL-60 cells were stimulated by fMLP (100 nM) for 
indicated times in suspension and lysed.  AKT phosphorylation at serine 473 (p-S473) 
was assessed by western blotting.  Total AKT was a loading control.  (B) Quantification 
of relative p-S473 AKT levels after fMLP stimulation for indicated times.  Values are 
normalized to the level in cells 60 sec after fMLP stimulation (=100%) and are means ± 
SEM (n = 4).  (C) Western blotting of p-S473 AKT and total AKT in cells with or without 
Rictor depletion.  dHL-60 cells were stimulated with 100 nM of fMLP for 1 or 5 min in 
suspension and lysed.  The blot for Rictor is also shown. (D) Quantification of relative p-
S473 AKT levels in dHL-60 cells with or without Rictor depletion 1 min after fMLP 
stimulation.  Each bar represents the mean ± SEM (error bars, n = 4).  Values are 
normalized to the level of p-S473 AKT in cells without fMLP stimulation (*, p<0.001).  (E) 
Western blotting of p-S473 AKT and p-T308 AKT in dHL-60 cells treated with AKTi-1/2 
of indicated concentrations.  Cells were pretreated with AKTi-1/2 for 30 min, stimulated 
with 100 nM fMLP for 1 minute and lysed.  Total AKT was used as a loading control.  (F) 
The number of polarized cells with or without AKTi-1/2 treatment (1 µM) in an fMLP 
gradient produced by the microfluidic device. 51 control cells and 43 AKTi-1/2 treated 
cells were analyzed.  Values are normalized to the number (100%) of cells without 
AKTi-1/2 treatment.  (G) Migration speeds of control and AKTi-1/2 treated dHL-60 cells 
(1 µM) in an fMLP gradient produced by the microfluidic device.  42 control cells and 39 
AKTi-1/2 treated cells were analyzed. 
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Figure 3.10.  (A) Quantification of S6K1 phosphorylation (p-T389) in dHL-60 cells with or 
without rapamycin or Torin1 treatment.  The values are normalized to the level of S6K1 
phosphorylation 5 min after stimulation and are means ± SEM (n = 4).  (B) Quantification 
of AKT phosphorylation (p-S473) in dHL-60 cells with or without rapamycin or Torin1 
treatment.  The values are normalized to the level of AKT phosphorylation in control cells 
1 min after fMLP stimulation and are means ± SEM (n = 4). 
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Figure 3.11. 
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Figure 3.11 (continued).  (A) Quantification of F-actin levels in suspended dHL-60 cells.  
Cells with or without mTOR depletion were stimulated with fMLP (100 nM) for various 
times in suspension and fixed for staining with fluorescently-labeled phalloidin.  
Fluorescence in stained cells was determined by flow cytometry.  Values are mean ± 
SEM (n = 4).  (B) Western blotting of Rictor in differentiated PLB-985 (dPLB-985) cells 
transfected with Rictor or non-targeting (NT) shRNAs.  GAPDH was a loading control. 
PLB-985 cells were infected with lentiviruses containing the various shRNAs and were 
differentiated for 5 d in the presence of DMSO.  (C-D) Quantification of F-actin levels in 
suspended dPLB-985 cells.  Cells with or without Rictor depletion were stimulated with 
100 nM (C) or 1 µM fMLP (D) for various times in suspension and fixed for staining with 
fluorescently-labeled phalloidin.  Fluorescence in stained cells was determined by flow 
cytometry.  Values are mean ± SEM (n = 4). 
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Figure 3.12.  (A) The levels of Rac-GTP in suspended dHL-60 cells with or without 
mTOR depletion.  Cells were stimulated with 100 nM of fMLP for 30 sec and lysed for 
the pulldown assay.  Levels of total Rac were used to show cell lysate input.  (B) 
Quantification of relative levels of Rac-GTP level with and without mTOR depletion. 
Each bar represents the mean ± SEM (error bars).  Values are normalized to the level of 
Rac-GTP (=100%) in cells without mTOR depletion (*, p<0.001).  (C) The levels of 
Cdc42-GTP in dHL-60 cells with or without mTOR depletion.  dHL-60 cells with or 
without mTOR depletion were stimulated with 100 nM of fMLP for 30 sec in suspension 
and lysed for the pulldown assay.  Levels of total Cdc42 were used to show cell lysate 
input.  (D) Quantification of relative levels of Cdc42-GTP with and without mTOR 
depletion.  Each bar represents the mean ± SEM (n = 4).  Values are normalized to the 
level of Cdc42-GTP (=100%) in cells without Rictor depletion (*, p<0.001). 
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Figure 3.13.  (A) Quantification of RhoA-GTP in suspended dHL-60 cells with or with 
Rictor depletion.  Cells were stimulated with fMLP (100 nM) for times indicated and 
lysed.  The level of RhoA-GTP was determined by the use of an absorbance-based 
RhoA G-LISA kit.  The y axis represents the normalized level of RhoA-GTP. Each bar 
represents the mean ± SEM (error bars) (n = 4).  Student’s t test was performed.  The 
asterisk indicates that the level of Rictor-depleted cells differ statistically from the control 
cells (*, p < 0.01).  (B) Quantification of RhoA-GTP in adherent dHL-60 cells with or with 
Rictor depletion.  Cells were plated on fibrinogen-coated plates for 30 minutes.  Cells 
were then stimulated by 100 nM fMLP for indicated times and lysed.  The level of 
RhoAGTP was determined as described above.  Each bar represents the mean ± SEM 
(error bars) (n = 4).  (C) Western blotting of Rictor and RhoGDI2 in dHL-60 cells with or 
without Rictor depletion.  Two separate Rictor shRNAs were used.  α-tubulin was a 
loading control. 
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Chapter # 4: Conclusion 
 
Migrating neutrophils exhibit a highly polarized morphology in which actin 
polymerization is localized to the leading edge (pseudopod), and activated myosin II is 
localized at the trailing edge (uropod) (Xu et al. 2003).  In order to maintain this polarity, 
these cells utilize a network of two distinct and divergent signaling pathways (Xu et al. 
2003).  These distinct and divergent signaling pathways, however, cannot completely 
explain persistent polarity and migration.  Matrix-specific substrate interactions are 
crucial in maintaining polarity and migration.  Yet little is known about these signaling 
events and how they cooperate with the divergent signaling pathways that promote 
polarity via actin polymerization at the front of the cell and myosin contraction at the 
back of the cell.   
Our results have identified Pyk2 as a beta2-integrin-dependent regulator of rear 
contraction in migrating neutrophil cells.  Pyk2 is specifically activated by beta2-integrin 
and depletion of Pyk2 causes a severe morphological defect that is exceedingly similar to 
the defect observed in cells in which components of the backness pathway have been 
perturbed.  Furthermore, we have shown that Pyk2 depletion causes a decrease in RhoA 
activity and myosin activity.  Depletion of p190RhoGEF (Rgnef), a 190kDa guanine 
exchange factor, causes the same morphological defect as Pyk2-depleted cells as well as 
a decrease in both RhoA activity and myosin activity at the rear of the cell.  Importantly, 
we have shown that Pyk2 interacts with p190RhoGEF and also with RhoA in neutrophils 
cells attached to beta2-integrin ligands.   
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Our findings indicate that Pyk2 mediates contraction by interaction with 
p190RhoGEF and RhoA thereby regulating the myosin contractility at the rear of the cell.  
These data elucidate a novel mechanism in which Pyk2 integrates matrix-specific 
substrate interactions with the signaling network responsible for the polarized 
morphology needed for neutrophil migration. 
This mechanism demonstrates how neutrophils integrate matrix-specific 
interactions to support polarity.  Similarly, neutrophils also integrate chemoattractant 
signaling to initiate polarity.  They interpret chemical gradients of chemoattractants to 
generate asymmetric accumulation of filamentous actin (F-actin) at the leading edge to 
provide the driving force for protrusion and polarity.  While this process has been 
extensively explored, it is still not fully understood.  
We describe a pivotal role for Rictor, a component of Mammalian Target of 
Rapamycin Complex 2 (mTORC2), in regulating assembly of the actin cytoskeleton 
during neutrophil chemotaxis.  Depletion of Mammalian Target of Rapamycin (mTOR) 
and Rictor, but not Raptor, impairs actin polymerization, leading edge establishment and 
directional migration in neutrophils stimulated with chemoattractants.  Intriguingly, 
depletion of mSin1, an integral component of mTORC2, causes no detectable defects in 
neutrophil polarity and chemotaxis.  In addition, experiments with chemical inhibition 
and kinase-dead mutants indicate that mTOR kinase activity and AKT phosphorylation 
are dispensable for chemotaxis.  Instead, our results suggest that the small Rho GTPases 
Rac and Cdc42 serve as the downstream effectors of Rictor to regulate actin assembly 
and organization in neutrophils.  Together, our findings reveal an mTORC2- and mTOR 
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kinase -independent function and mechanism of Rictor in the regulation of neutrophil 
chemotaxis. 
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